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A hallmark of vascular aging, central arterial stiffness is the primary determinant of hypertension 
in older adults and an important predictor of cardiovascular events and mortality.  Few studies of 
older adults have evaluated the longitudinal association of arterial stiffness with cognitive and 
physical declines, two common consequences of vascular disease.  We sought to characterize the 
relationships among aortic pulse wave velocity (PWV), a measure of central arterial stiffness, 
cognitive and physical declines and mortality risk among community-dwelling older adults 
participating in the Health, Aging and Body Composition (Health ABC) study.  In an analysis of 
the Health ABC Cognitive Vitality Substudy, poorer performances in several cognitive domains 
were associated with accelerated gait speed decline, consistent with a shared cerebrovascular 
pathogenesis underlying cognitive and physical declines in aging.  A second analysis of the 
substudy identified PWV as a predictor of longitudinal decline in psychomotor speed; this 
domain-specific association may reflect a vulnerability of the deep white matter to cerebral 
microvascular disease in the presence of aortic stiffness.  In an analysis of the full Health ABC 
cohort, higher PWV was independently associated with slower gait at baseline and throughout 
the study period in participants with peripheral arterial disease (PAD), suggesting synergistic 
roles of arterial stiffness and PAD in mobility decline.  Finally, in the full cohort rates of decline 
in the Modified Mini-Mental State Exam (3MS) and gait speed predicted mortality independent 
of each other, baseline performance and risk factors, demonstrating a prognostic value for 
 iv 
repeated assessments of both cognitive and physical performance in initially well-functioning 
older adults.  The public health relevance of these findings is the potentially clinically important 
influence of central arterial stiffness to both cognitive and physical function, two central facets of 
successful aging.   
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1.0  INTRODUCTION 
Hypertension is increasingly recognized as a formidable public health threat to aging 
populations.  More than 70% of US adults age 65 or older are hypertensive, defined as blood 
pressure of 140/90 mmHg or greater (McDonald, Hertz, Unger, & Lustik, 2009).  Despite 
advances in awareness and treatment, prevalence is rising while control rates remain low (Hajjar 
& Kotchen, 2003).  Uncontrolled blood pressure is a primary risk factor for heart disease and 
stroke, the first and third leading causes of death in the US.  While these clinical risks were 
identified many years ago, cognitive and physical functional consequences of hypertension 
continue to emerge (Skoog & Gustafson, 2006) (Dahlof, 2007).  Effective prevention and 
treatment of this potentially devastating condition are central to the promotion of successful 
aging.  
Improved strategies to control blood pressure may develop from new understanding of 
the vascular alterations underlying hypertension in aging.  Thickening and stiffening of the 
arterial walls are two well-described hallmarks of subclinical vascular disease in older adults 
(Lakatta, 1993); these risky features of arterial aging are both determinants and consequences of 
hypertension.  Since the 1960s vascular imaging technology has provided valuable insight into 
these distinct, though often co-occurring structural changes.  Noninvasive measurement of 
arterial stiffness has received growing attention in the investigation of arterial aging.     
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A measure of central arterial stiffness, aortic-pulse wave velocity (PWV) predicts 
mortality and morbidity independent of hypertension and other traditional vascular risk factors 
(Sutton-Tyrrell et al., 2005) (Matsuoka et al., 2005).  During systole, ejection of the blood from 
the left ventricle produces a pressure wave that travels toward the periphery.  PWV reflects the 
speed of the pressure wave along the arterial tree; higher values of PWV reflect greater aortic 
stiffness.  Risk associated with elevated PWV has been attributed to two co-occurring 
mechanisms: 1) gradual loss of the cushioning capacity of the vasculature, associated with small-
vessel injury of the target organs; and 2) early wave reflection from the periphery, accompanied 
by an increase in cardiac afterload (O'Rourke, 2007).  These age-associated vascular changes 
increase risk of hypertension, heart attack, stroke, dementia and renal disease (Zieman, 
Melenovsky, & Kass, 2005). 
Stiffening of the large arteries reflects a gradual dysregulation of the structural 
components of the vascular wall.  Inflammatory and neuroendocrine changes in aging alter the 
balance of collagen and elastin, the primary scaffolding proteins which provide the structural 
integrity and elasticity of the vessel wall (Zieman et al., 2005).  Because age is the primary risk 
factor for vascular stiffening, these structural alterations have been considered an indicator of 
vascular aging (O'Rourke, 2007) (Najjar, Scuteri, & Lakatta, 2005).  In conflict with the 
assumption that vascular aging is unmodifiable, several traditional risk factors contribute to 
vascular stiffening independent of chronological age (Najjar et al., 2005).  Hypertension, insulin 
resistance (Bhuiyan, Srinivasan, Chen, Paul, & Berenson, 2006) and excess salt intake (Zieman 
et al., 2005) may each accelerate the accumulation of collagen and degradation of elastin which 
contribute to arterial stiffening (O'Rourke, 2007).  These findings highlight the potential to slow 
vascular stiffening through the control of modifiable risk factors.  
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In this review, we outline the epidemiology of hypertension in aging and the 
pathophysiology of underlying arterial stiffness.   We then describe current methods of arterial 
stiffness measurement and review the relationships of arterial stiffness with both clinical and 
functional outcomes in aging.  We consider the potential influences of missing data in 
observational studies of arterial stiffness and review methods of sensitivity analysis to account 
for nonrandom missingness.  Finally, we discuss the public health implications of arterial 
stiffening and potential strategies to slow or reverse this risky process of arterial aging. 
1.1 EPIDEMIOLOGY 
The National Health and Nutrition Examination Survey (NHANES) 1999-2000 reported that 
28.7% of US adults surveyed were hypertensive, defined as measured blood pressure of 140/90 
or greater or reported use of antihypertensive medications (Hajjar & Kotchen, 2003).  This 
finding represents a 3.7% increase in hypertension prevalence from 1988-1991, a trend which 
reflects the aging of the US population (Franklin, 2006a).  In 1999-2000 prevalence increased 
with age (65% among those age 60 years or older), tended to be higher in women (30%), and 
was highest among non-Hispanic blacks (34%).  Of those identified as hypertensive, 69% were 
aware of their condition, 58% were treated and hypertension was controlled in 31%.  Control 
rates were significantly lower in those age 60 years or older, despite the higher rate of treatment 
in this age group (Hajjar & Kotchen, 2003).  These data are consistent with the well-known 
difficulty in successfully treating isolated systolic hypertension, the predominant form of 
hypertension in older adults (Franklin, Jacobs, Wong, L'Italien, & Lapuerta, 2001).  
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1.2 PATHOPHYSIOLOGY 
Vascular stiffening underlying hypertension in aging preferentially affects the large conduit 
arteries while sparing the peripheral vasculature.  Hemodynamic forces in aging and 
hypertension, excess salt intake, and impaired glucose regulation each disrupt the balance of 
scaffolding proteins within the vascular wall.  Arterial stiffening is often attributed to 
accumulation and cross-linking of collagen and fragmentation of elastin, two prominent 
structural components which provide the structural integrity and elasticity of the vessel wall 
(Zieman et al., 2005).  
Multiple cellular and neuroendocrine mechanisms account for the dysregulation of 
collagen and elastin that characterizes arterial stiffening (Zieman et al., 2005).  Catabolic matrix 
metalloproteases (MMPs) enzymatically degrade the extracellular matrix of the vessel wall, 
altering the composition of collagen and elastin in the intima and media layers.  MMP activity is 
stimulated by inflammatory cells, oxidized LDL, reactive oxygen species, and a high flow state.  
Additionally, advanced glycation end products (AGEs), metabolic by-products that accumulate 
in aging and glucose intolerance (Brownlee, 1995), form irreversible cross-links between 
collagen molecules which contribute to arterial stiffening.  AGEs may also influence endothelial 
dysfunction by inhibiting production of nitric oxide, a powerful vasodilator which regulates 
smooth muscle tone; resulting structural alterations may heighten the inflammatory response to 
vascular injury and promote atherosclerotic plaque formation (Zieman et al., 2005).  Finally, 
angiotensin II contributes directly to vascular stiffening by stimulating collagen formation and 
matrix remodeling (Najjar et al., 2005) and reducing elastin synthesis; these mechanisms are 
amplified in hypertension and with high-sodium intake.  Sodium further impairs nitric oxide 
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availability and stimulates production of reactive oxygen species, altering vascular tone and 
accelerating vascular stiffening (Zieman et al., 2005).      
1.3 ARTERIAL STIFFNESS MEASUREMENT 
The gold standard of arterial stiffness measurement, aortic pulse wave velocity (PWV) is a 
reliable and valid (Laurent & Boutouyrie, 2007), noninvasive measure that independently 
predicts cardiovascular events and mortality in older adults (Sutton-Tyrrell et al., 2005).  The 
measure is more discriminant than pressure measured in the arm (brachial pressure) because 
PWV directly measures the central pressure that is exerted on the target organs, while brachial 
pressure is augmented by wave reflection from the periphery (Hirata, Kawakami, & O'Rourke, 
2006).  PWV measurement involves the simultaneous recording of pressure waves at two 
proximal and distal sites.  The carotid and femoral arteries are common recording sites; these 
locations allow noninvasive measurement of pulse waveforms (Oliver & Webb, 2003).  The 
PWV may be measured by pressure-sensitive transducers, Doppler ultrasound, or applanation 
tonometry, where the pressure within a micromanometer flattened next to an artery reflects the 
pressure within the artery.  Each method records the time delay between the arrival of a specific 
part of the pulse wave, often the foot of the wave, at each recording site.  The distance between 
the recording sites is measured over the body surface.  PWV is calculated as the distance in m or 
cm divided by the time delay (m/s or cm/s).  Higher values of PWV reflect greater vascular 
stiffness.  A typical PWV value is 500 cm/s in a 20-year old and 1200 cm/s in an 80-year old, a 
six-fold difference over 60 years (Laurent et al., 2006; O'Rourke, 2007; O'Rourke, Staessen, 
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Vlachopoulos, Duprez, & Plante, 2002).  In the Health, Aging and Body Composition (Heath 
ABC) Study, replicate testing of aortic PWV demonstrated high reproducibility between 
sonographers and between readers, as indicated by intraclass correlations >0.80 (Sutton-Tyrrell 
et al., 2005). 
 Several alternative methods are considered indirect measurements of arterial stiffness 
(Oliver & Webb, 2003).  Ultrasound imaging of the carotid artery allows calculation of arterial 
distensibility by relating the change in vessel diameter to the distending pressure.  The validity of 
this method is limited by the influence of pulse pressure amplification on the assumed pressure 
of the artery.  Various methods of analyzing the arterial pulse waveform provide the 
augmentation index (AIx), the proportion of central pulse pressure that results from wave 
reflection.   Although the AIx is primarily determined by arterial stiffness, the measure is also 
influenced by the elasticity and diameter of small arteries and arterioles (Oliver & Webb, 2003).   
1.4 CLINICAL AND SUBCLINICAL CONSEQUENCES OF ARTERIAL STIFFNESS  
1.4.1 Hypertension 
In younger adults, narrowing of the arteries increases vascular resistance, which promotes co-
occurring rises in systolic and diastolic blood pressure.   By contrast, stiffening of the large 
conduit arteries in aging commonly manifests as isolated systolic hypertension, the predominant 
form of hypertension in older adults (Franklin, 2006b). This pattern of elevated systolic pressure 
and low or normal diastolic pressure reflects the altered wave mechanics as vessels stiffen with 
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advancing age.  Arterial stiffening is accompanied by early reflection of the pulse wave from 
peripheral vessels, which reaches the origin of the aorta at systole rather than diastole (Schiffrin, 
2004).  This shifted timing increases cardiac afterload (the pressure that the left ventricle must 
generate in order to eject blood into the aorta) while failing to bolster coronary perfusion during 
diastole (O'Rourke, 2007).  These mechanical alterations contribute to a widening of the pulse 
pressure and isolated systolic hypertension (Schiffrin, 2004). 
Several studies have identified arterial stiffness as an important risk factor for 
hypertension in older adults.  In the Baltimore Longitudinal Study of Aging (BLSA), elevated 
PWV predicted a longitudinal increase in SBP and incident hypertension over ten years (HR 1.10 
per 100 cm/s increase in PWV, 95% CI 1.00 – 1.30) in normotensive or untreated hypertensive 
adults (Najjar et al., 2008).  These relationships were not explained by demographics, BMI, 
smoking, heart rate, lipids, or fasting glucose.  The Atherosclerosis Risk in Communities (ARIC) 
Study found a similar association of arterial stiffness with incident hypertension in normotensive 
men and women (Liao et al., 1999).  Arterial stiffness was measured using B-mode ultrasound of 
the common carotid artery.  Independent of vascular risk factors, lower arterial diameter change 
was associated with higher risk of incident hypertension over six years.  This relationship is 
consistent with the association of lower aortic strain, or the percent change in aortic diameter 
from systole to diastole, with incident hypertension in a large cohort of normotensive older 
adults (Dernellis & Panaretou, 2005).  These findings implicate elevated central arterial stiffness 
as an important determinant of hypertension in aging.  In addition to traditional risk factors, 
arterial stiffness measurement may identify those at high risk for incident hypertension who may 
benefit from early intervention. 
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1.4.2 Cardiovascular Events and Mortality 
Arterial stiffness is increasingly recognized as an independent predictor of cardiovascular events 
and mortality in older adults.  In the Health, Aging and Body Composition (Health ABC) Study, 
higher PWV was significantly associated with higher risk of all-cause mortality (relative risk 1.5, 
1.6 and 1.7 for PWV quartiles 2, 3, and 4 versus 1; p = 0.019), cardiovascular mortality (relative 
risk 2.1, 3.0, and 2.3 for PWV quartiles 2, 3, and 4 versus 1; p = 0.004), coronary heart disease 
(CHD) and stroke (Sutton-Tyrrell et al., 2005).  These relationships remained after adjustment 
for demographics, systolic blood pressure, prevalent cardiovascular disease, and other risk 
factors.  Additionally, the authors identified a potential threshold effect of PWV; elevated 
cardiovascular risk was limited to the three highest quartiles of PWV.  These data suggest that 
low PWV may be a marker of successful vascular aging.   
Earlier studies of arterial stiffness described similar cardiovascular risk in participants 
with hypertension or renal disease.  In a cohort of 1980 hypertensive patients, each 500 cm/s 
increase in PWV was associated with a 2.14 times higher risk of all-cause and 2.35 times higher 
risk of cardiovascular mortality.  These associations after adjustment for prevalent cardiovascular 
disease, age, and diabetes (Laurent et al., 2001).  In 242 patients with end-stage renal disease, 
each 100 cm/s higher PWV was associated with a 14% increase in both all-cause and 
cardiovascular mortality after adjustment for vascular risk factors (Blacher et al., 2003).  These 
findings highlight the potential value of arterial stiffness measurement in risk stratification for 
early intervention.   
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1.4.3 Target Organ Damage 
Elevated arterial stiffness is closely associated with small vessel disease of the target organs 
(Mitchell, 2008).  The brain and kidney, both passively perfused throughout the cardiac cycle, 
are particularly susceptible to vascular injury; stiffened vessels transmit, rather than cushion, 
damaging flow pulsations into the small vessels of these target organs (O'Rourke, 2007).  
Microvascular remodeling and impaired regulation of blood flow may result in small-vessel 
disease of the brain and kidney, which may contribute to decline in cognitive and renal function 
(Mitchell, 2008).  Common clustering of microvascular brain abnormalities and chronic kidney 
disease suggest a shared vascular pathology underlying declines in cognitive and renal function 
(Thompson & Hakim, 2009).  
The contribution of arterial stiffness to renal dysfunction has recently received 
growing attention.  In patients with end stage renal disease, isolated systolic hypertension has 
been attributed to stiffness of the large arteries and resulting early wave reflections.  Under these 
conditions, the diminished filtering function of the kidney requires continued increase of systolic 
pressure to maintain sodium balance.  Subsequent arterial stiffening may then accelerate renal 
dysfunction via microvascular injury, establishing a dangerous bidirectional relationship between 
the two disease processes (Safar, London, & Plante, 2004).   
Several studies have found inverse associations of arterial stiffness with renal function 
in older adults.  In a cohort of 1290 adults with normal or low plasma creatinine (≤ 130 umol/L), 
higher PWV was associated with lower creatinine clearance independent of age, gender and 
blood pressure (Mourad et al., 2001).  The Health ABC Study found that higher PWV was 
associated with higher cystatin C in 2,468 community-dwelling older adults after adjustment for 
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demographics and risk factors (Madero et al., 2009b).  These findings suggest that small vessel 
alterations may contribute to kidney dysfunction in aging.  Assessment of large arterial stiffness 
may serve to identify individuals at high risk for kidney disease. 
Arterial stiffness has also been implicated in the development of small-vessel disease 
in the brain.  This vascular pathology closely associated with hypertension (Longstreth et al., 
1996) may manifest as white matter hyperintensities (WMH) or subcortical infarcts apparent on 
brain MRI.  Commonly detected in older adults (Manolio et al., 1994), WMH are associated with 
cognitive decline, depression, disability, and incident stroke  (Ovbiagele & Saver, 2006).  In a 
recent study of 167 hypertensive patients, higher PWV was associated with greater volume of 
white matter hyperintensities and presence of lacunar infarcts (OR per SD higher PWV: 1.78; 
95% CI: 1.06-2.99; p < 0.05) (Henskens et al., 2008).  These relationships were independent of 
age, sex, brain volume, mean arterial pressure and heart rate.  Higher PWV was further 
associated with the presence of periventricular hyperintensities independent of age and blood 
pressure in 132 community-dwelling older adults (Ohmine et al., 2008).  These findings suggest 
that arterial stiffness may explain the relationship of hypertension with cerebral small-vessel 
disease; stiffened vessels may transmit highly pulsatile flow into the fragile vasculature deep 
within the brain (O'Rourke, 2007).  The associated dysregulation of cerebral blood flow may 
play a prominent role in cognitive decline with advancing age (Iadecola, Park, & Capone, 2008). 
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1.5 ARTERIAL STIFFNESS AND COGNITIVE FUNCTION 
Hypertension is an important risk factor for cognitive decline and dementia (Breteler, 2000; de la 
Torre, 2002).  In both Alzheimer disease (AD) and vascular dementia (VaD), vascular risk 
factors may alter blood flow regulation in the cerebral small vessels.  The resulting energy crisis 
and breakdown of the blood-brain barrier may manifest in neuronal cell injury or death, or 
acceleration of AD pathology (Iadecola et al., 2008).  The contribution of arterial stiffness to 
these disease processes has received growing attention.  Several studies have described 
independent, inverse associations of PWV with cognitive function in older adults (Table 1), 
suggesting that interventions to preserve cognitive function in aging should target both 
hypertension and underlying arterial stiffness.  
Elevated PWV has been associated with lower cognitive function in several cross-
sectional studies of older adults.  In a cohort of 308 older adults with complaints of memory loss, 
carotid-femoral PWV was higher in participants with vascular dementia (VaD) or Alzheimer’s 
disease (AD) relative to those without cognitive impairment (Hanon et al., 2005), and in 
participants with mild cognitive impairment (MCI) relative to those with normal cognitive 
function.  Similarly, in a cohort of 203 community-dwelling older adults aged 85, PWV was 
higher in participants with impaired relative to normal cognitive function (Fukuhara et al., 2006).  
These relationships were not explained by traditional vascular risk factors. 
One study further investigated the relationships of subclinical vascular disease with 
function in specific cognitive domains (Muller, Grobbee, Aleman, Bots, & van der Schouw, 
2007).  Carotid intima-media thickness (IMT), a marker of subclinical atherosclerosis, was 
evaluated by ultrasound of the left and right common carotid arteries.  Arterial stiffness was 
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measured by carotid-femoral pulse wave velocity.  In this community-dwelling cohort, higher 
IMT was associated with lower memory scores after adjustment for age and education.  
Associations of higher PWV with lower processing speed and executive function scores 
approached significance.  The differential relationships of IMT and PWV with specific cognitive 
domains suggest that these measures may be sensitive to different stages of cognitive decline.    
Few studies have investigated the association of arterial stiffness with cognitive 
decline, with mixed results.  In 2,767 in the Rotterdam Study (mean age ± SD 72.0 ± 6.7 years), 
elevated PWV was cross-sectionally associated with poorer executive function cross-sectionally 
but not with cognitive decline over five years or risk of dementia over eight years (Poels et al., 
2007).  However, higher PWV was associated with greater cognitive decline in the Baltimore 
Longitudinal Study of Aging (BLSA) (Waldstein et al., 2008).  In this community-based cohort, 
582 participants (mean age ± SD 54.3 ± 17.1 years), received baseline assessment of PWV and 
cognitive testing on 1 to 6 occasions over 11 years.  Higher PWV was associated with 
accelerated declines in verbal learning, memory, and global cognitive function but not executive 
function or processing speed after adjustment for vascular risk factors.  These findings contrast 
with associations of white matter disease on brain MRI with decline in executive function and 
processing speed but not other cognitive domains (Jokinen et al., 2009; Prins et al., 2005).  The 
inconsistent results of the Rotterdam Study and the BLSA may reflect important differences in 
the age distributions of the study populations, duration of follow-up, and selected cognitive 
assessments.  Importantly, nonrandom withdrawal of less healthy participants is likely to 
underestimate the associations of arterial stiffness with cognitive decline in both cohorts.  
Sensitivity analyses that account for nonrandom dropout missingness may clarify the influence 
of bias in future studies of arterial stiffness and functional decline.    
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Finally, one study investigated the relationships of arterial stiffness, white matter 
disease, and cognitive function in hypertensive patients with complaints of memory loss 
(Kearney-Schwartz et al., 2009).  Higher PWV was associated with greater risk of memory 
impairment in men but not women after adjustment for vascular risk factors; this sex-specific 
relationship may reflect the higher rate of memory impairment and greater burden of subclinical 
vascular disease in men in this population.  Further, augmentation index (AI), a measure of 
vascular stiffness, but not PWV was associated with severity of white matter lesions on brain 
MRI, suggesting that cerebral small vessel disease may mediate the relationship of arterial 
stiffness with lower cognitive function.  Longitudinal analyses are needed to clarify the 
contribution of arterial stiffness to progression of both small vessel disease and cognitive decline. 
1.6 ARTERIAL STIFFNESS AND PHYSICAL FUNCTION 
Estimated to affect 15% of adults aged 70 years or older (Selvin & Erlinger, 2004), obstructive 
peripheral arterial disease (PAD) is an important predictor of functional decline (McDermott et 
al., 2004), disability (Brach et al., 2008), and mortality (Newman et al., 1999).  PAD is 
associated with elevated arterial stiffness as measured by aortic PWV (van Popele et al., 2001), 
consistent with the hypothesis that atherosclerosis may accelerate arterial stiffening (van Popele 
et al., 2001).  In patients with PAD higher PWV is associated with lower functional capacity 
(Amoh-Tonto, Malik, Kondragunta, Ali, & Kullo, 2009), and reduction of PWV may improve 
walking performance (Ahimastos, Dart, Lawler, Blombery, & Kingwell, 2008).  These findings 
may reflect impaired diastolic function in the presence of aortic stiffness.  Elevated arterial 
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stiffness may further contribute to resistance vessel hypertrophy and increased vascular 
resistance (Intengan & Schiffrin, 2000; Park & Schiffrin, 2001), impeding blood flow to the 
peripheral microvasculature (Mitchell et al., 2005); however, few studies have evaluated the 
potential contribution of arterial stiffness to mobility decline in aging.     
1.7 THE MICROVASCULAR FRONTAL-SUBCORTICAL SYNDROME OF AGING 
Many studies have identified a close relationship between cognitive and physical performance in 
older adults, suggesting a shared pathogenesis of declines in both domains (Pugh & Lipsitz, 
2002).  Age-related dysfunction in cognition and motor control has been characterized as a 
microvascular frontal-subcortical syndrome of aging (Pugh & Lipsitz, 2002), in which cerebral 
small-vessel disease preferentially disrupts an extensive network of neural circuits that mediate 
executive cognitive function and movement.  This common cerebrovascular pathology in older 
adults may manifest as white matter lesions or lacunar infarcts on brain MRI.    
White matter disease in aging is generally attributed to cerebral ischemia associated 
with hypertension (Vermeer, Longstreth, & Koudstaal, 2007).  Myelin loss represented by 
diffuse white matter lesions often occurs in the periventricular regions and may reflect transient 
periods of hypoperfusion; by contrast, focal lesions often represent completed lacunar infarcts 
due atherosclerotic obstruction of the small subcortical arterioles.  Age, hypertension, and 
diabetes are well-established risk factors for white matter lesions (Launer, 2004).   
Several mechanisms have been hypothesized to explain cerebrovascular alterations in 
aging and hypertension (Iadecola et al., 2008).  Highly pulsatile flow through stiffened vessels 
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may accelerate the narrowing of the cerebral vasculature, impeding delivery of energy substrates 
and nutrients to active brain cells.  The resulting state of chronic hypoperfusion may directly 
injure cerebral white matter or allow toxic metabolic byproducts to accumulate within the brain 
and blood vessels.  Moreover, stiffening and thickening of the cerebral vasculature may 
contribute to endothelial dysfunction and subsequent breakdown of the blood-brain barrier; 
toxins, proteases, or other substances in the blood may then enter the brain interstitial space and 
injure surrounding neurons and glial cells.  This mechanism may further accelerate the narrowing 
of the lumen and resulting ischemia (Wardlaw, Sandercock, Dennis, & Starr, 2003). 
In well-functioning older adults, white matter lesions are associated with poorer 
executive function, information processing, and gait (Black, Gao, & Bilbao, 2009). These 
relationships are consistent with the diffuse anatomy of frontal-subcortical circuits which 
mediate these cognitive and motor processes; vascular insult to any region of these extended 
tracts may result in compromised function (Pugh & Lipsitz, 2002).  Further, because much of the 
deep white matter lies within watershed zones located at the boundaries of large vessel perfusion 
territories, these regions are vulnerable to ischemic injury (Pugh & Lipsitz, 2002).  Resulting 
white matter changes may contribute to co-occurring declines in cognitive and physical function 
with advancing age.   
1.7.1 Relationships of cognitive and physical function in aging 
Cross-sectional analyses have found associations of a variety of cognitive processes with gait 
speed and risk of falls (Ble et al., 2005; Holtzer et al., 2007; Rosano, Simonsick et al., 2005).  
Several studies of simultaneous cognitive and motor performance suggest that compromised 
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executive function and attention may be particularly important to explain gait slowing with age 
(Coppin et al., 2006; Holtzer, Verghese, Xue, & Lipton, 2006); these specific cognitive domains 
may i nfluence mobility t hrough t he pl anning a nd e xecution of  motor t asks a nd i nhibition of  
competing demands from the environment.  
Longitudinal studies of older adults have identified a seemingly reciprocal relationship 
between cognitive and phys ical function.  I n t he I talian Longitudinal S tudy on A ging ( ILSA), 
deficits in attention predicted decline in motor pe rformance a fter three ye ars (Inzitari, 
Baldereschi e t al., 200 7).  P oorer gl obal and  exe cutive function were a lso associated with 
accelerated gait speed decline over three years in Health ABC (Atkinson et al., 2007); conversely 
slower ga it predi cted decline i n attention an d psychomotor sp eed over f ive y ears (Inzitari, 
Newman e t a l., 2007) .  T hese f indings ar e co nsistent w ith a sha red pathogenesis unde rlying 
cognitive and mobility declines and further suggest that subtle executive and attention deficits 
may manifest i n m otor i mpairment, e ven be fore s uch de ficits c an be  detected.  I t i s unc lear 
whether a ssociations b etween cognitive and  gait d eclines exis t a cross m ultiple cogni tive 
processes or  ar e restricted to several spe cific domains.  L ongitudinal b rain imaging s tudies of  
older adu lts may clarify the m echanisms und erlying co-occurring de clines i n c ognitive a nd 
physical performance, two central facets of successful aging. 
1.7.2 Cognitive and physical declines as predictors of mortality 
Both cognitive and physical performance measures are valuable prognostic tools in older adults 
(Guralnik et al., 2000; Spiers et al., 2005).  In the Cardiovascular Health Study, lower scores on 
the Digit Symbol Substitution Test (DSST) and slower gait were each associated with higher risk 
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of incident disability and mortality over eight years (Rosano, Newman, Katz, Hirsch, 
& Kuller, 2008).  Co-occurring cognitive and physical declines in this cohort may reflect a 
shared cerebrovascular pathogenesis or general physiological deterioration associated with 
inflammation or oxidative stress. 
Few studies have evaluated whether changes in cognitive or physical function predict 
mortality independent of each other or baseline performance.  Independent associations of 
declines in each domain with mortality may suggest a prognostic value for repeated cognitive 
and physical assessments.  Further, if risk associated with functional declines is found attenuated 
in older adults who are initially high-functioning, these data may stress the importance of 
baseline performance as an indication of functional reserve (Newman et al., 2009; Stern, 2009).   
1.8 ANALYSIS OF LONGITUDINAL DATA WITH CENSORING 
Two recent studies evaluated the associations of elevated PWV with cognitive decline in 
community-dwelling older adults, with mixed results (Poels et al., 2007; Waldstein et al., 2008).  
These data are expected to underestimate this relationship in the population, because participants 
who experienced the greatest declines may have been unable complete the study.  In general, a 
significant challenge to observational studies is nonrandom censoring, or dropout related to 
unobserved characteristics of study participants.  This process may be especially problematic in 
studies of aging, where a healthy survivor effect is often an important source of bias.   
Relationships between a risk factor and an outcome are often underestimated when 
less healthy participants are more likely to drop out of the study.  For example, the Systolic 
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Hypertension in the Elderly Program (SHEP) identified a significant protective effect of 
antihypertensive therapy on cognitive function only after accounting for nonrandom censoring 
(Di Bari et al., 2001).  Sensitivity analysis of longitudinal data with dropouts is useful in 
evaluating the robustness of parameter estimates and standard errors to missing data.  Two 
commonly used methods of sensitivity analysis are multiple imputation (MI) and inverse 
probability weighted estimating equations (Mazumdar et al., 2007).  
1.8.1 Multiple imputation 
MI involves replacing missing data with multiple sets of plausible values, allowing each filled in 
dataset to be analyzed using standard methods.  The results of these analyses are combined to 
calculate the mean of the multiple parameter estimates and a variance estimate that reflects both 
missing-data uncertainty and sample variation.  MI may be performed using SAS Proc MI or MI 
ANALYZE.  These procedures allow the analyst to select from several methods of imputation 
appropriate for different types of missing data patterns (Mazumdar et al., 2007). 
When there is no missing data before a dropout (a monotone pattern), parametric 
regression methods or weighted estimation procedures may be used to impute missing data.  The 
parametric regression method involves fitting a model for each variable with missing data using 
other available variables as covariates.  The coefficients from this model are then applied to the 
available data to impute the missing outcomes.  The weighted estimation method involves fitting 
a model for the probability of missingness given a set of observed covariates.  This conditional 
probability, or propensity score, is calculated for all observations subject to dropout at a specified 
time (Rosenbaum & Rubin, 1984).  Observations are then grouped by propensity score and 
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missing data are imputed using a Bayesian bootstrap imputation method within each group, 
where values are resampled with replacement from the observed data (Mazumdar et al., 2007).   
A third, more complex method of imputation is preferred when the missing data 
pattern is unknown. The Markov Chain Monte Carlo (MCMC) method involves simulating 
random draws of missing data from a probability distribution via Markov chains, or sequences of 
random variables whose probabilities at a given time depend on the value at the previous time.  
The random draws generate multiple distributions of missing data, which are then used for 
inference (Schafer, 1997).    
An important limitation of MI methods is the potential for misspecification of the 
model used for imputation.  Additionally, most MI methods assume missing data are missing at 
random (MAR), where the probability of missingness does not depend on unobserved outcomes 
but may depend on observed covariates.  If missing data are missing not at random (MNAR), 
where the probability of missingness is related to unobserved data values, a model must be 
specified for the dropout procedure in conjunction with one of the inferential procedures 
described above.  The drop-out process may be modeled by selection models or pattern-mixture 
models, which differ in their treatment of the drop-out process and outcome process (Mazumdar 
et al., 2007). 
1.8.2 Inverse probability weighted estimating equations  
Generalized estimating equations (GEE) are often used to analyze longitudinal data when the 
pattern of correlation between repeated measurements is unknown (Zeger, Liang, & Albert, 
1988).  GEE provides unbiased estimates when data are missing completely at random (MCAR), 
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where the probability of missingness does not depend on observed or unobserved outcomes.  
When data are MAR, inverse probability weighted estimating equations may be used to adjust 
for the propensities for dropout (Fitzmaurice, Laird, & Ware, 2004).  In this method, a model is 
fitted for the probability that a variable is observed, given a set of covariates.  A weighting 
variable is then calculated as the inverse of the estimated probability for each individual; these 
weights may then be applied to GEE analyses of the outcome of interest.  For example, if a 
participant has a ¼ probability of completing the study, data from this individual would 
contribute to the analysis once for herself and three times for those who did not complete the 
study (Fitzmaurice et al., 2004).  An advantage of this approach is the flexibility in modeling the 
outcome.  However, biased estimates may result if the model for the probability of completing 
the study is not correctly specified (Mazumdar et al., 2007).     
1.9 INTERVENTIONS TO REDUCE ARTERIAL STIFFNESS 
A variety of interventions have been shown to reduce arterial stiffness in adults (Boutouyrie, 
Laurent, & Briet, 2008).  Lifestyle interventions with demonstrated success include exercise 
training, weight loss, salt restriction, and moderate alcohol consumption; pharmaceutical 
treatments include antihypertensive medications, treatments of congestive heart failure, statins, 
antidiabetic medications, hormone replacement therapy, and advanced-glycation end product 
(AGE) breakers.  However, the reduction of arterial stiffness by these interventions may not be 
independent of blood pressure lowering.  As the dangers of vascular stiffening are increasingly 
 21 
 
recognized, there is growing interest in the potential of antihypertensive medications to slow or 
reverse this common process in aging vessels.    
Antihypertensive medications that target the renin-angiotensin-aldosterone system 
(RAAS) have recently shown promise to combat arterial stiffening with age.  In older adults, 
elevated RAAS activity, including increased circulation of the powerful vasoconstrictor 
angiotensin II, promotes arterial inflammation and fibrosis which contribute to vascular 
stiffening (Najjar et al., 2005).  In a few studies, agents with RAAS involvement reduced arterial 
stiffness seemingly independent of blood pressure lowering (Mahmud & Feely, 2004).  The 
angiotensin-converting enzyme (ACE) inhibitor ramipril increased arterial compliance and 
decreased PWV in patients with peripheral arterial disease; these effects were not explained by 
the extent of blood pressure reduction (Ahimastos, Natoli, Lawler, Blombery, & Kingwell, 
2005).  Similarly, several angiotensin II receptor blockers were found to reduce PWV 
independent of blood pressure lowering in hypertensive patients (Agata et al., 2004; Sasamura, 
Kitamura, Nakamura, Ryuzaki, & Saruta, 2006).  These data suggest a potential for current 
antihypertensive medications to prevent or reverse vascular alterations associated with the 
RAAS.  Further research is needed to evaluate the hypothesized causal link between specific 
agents, reduced vascular stiffening and disease risk independent of the effect of blood pressure 
lowering.     
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1.10 PUBLIC HEALTH IMPLICATIONS 
Low rates of hypertension control in older adults (Hajjar & Kotchen, 2003) are consistent with 
the widely recognized difficulty in successfully treating isolated systolic hypertension (ISH), the 
predominant form of hypertension in aging (Franklin et al., 2001).  Because arterial stiffness is 
the primary determinant of ISH (Franklin, 2006a), there is significant incentive to understand 
both the pathophysiology and consequences of this risky vascular alteration that progresses with 
age.  Many studies have identified independent contributions of arterial stiffness to risk of 
cardiovascular events and mortality; several recent publications further implicate elevated 
arterial stiffness as a potential determinant of target organ damage and functional decline.  While 
the clinical benefits of blood pressure control are well-established, more work is needed to 
evaluate the anticipated success of interventions that target both hypertension and underlying 
arterial stiffness. 
1.11 SUMMARY 
Aging populations have encountered an unprecedented burden of chronic disease and disability, 
highlighting glaring deficiencies in the prevention and control of hypertension.  While clinical 
risks associated with hypertension are well-known, functional consequences of chronically 
elevated blood pressure are under recognized.  Improved strategies to extend the healthy lifespan 
may depend on new understanding of the vascular alterations underlying hypertension in older 
adults.  PWV, a measure of aortic stiffness, is a more discriminant measure of cardiovascular and 
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mortality risk than systolic pressure measured in the arm because PWV directly reflects the 
central pressure that is applied to the target organs.  Several recent studies of older adults further 
implicate central arterial stiffness as an independent predictor of hypertension and cognitive 
decline. 
Cerebral small-vessel disease, a common manifestation of ischemic injury in older 
adults, may in part explain the inverse association of arterial stiffness with cognitive function in 
older adults.  Executive and motor functions may be particularly vulnerable to vascular damage 
secondary to arterial stiffness; co-occurring declines in these domains are hypothesized to reflect 
a shared cerebrovascular pathogenesis or general physiological deterioration.  Although many 
studies have identified an inverse relationship of PWV with cognitive function cross-sectionally, 
an association of PWV with longitudinal cognitive decline has not been well-established.  The 
few longitudinal studies that have investigated this relationship have been limited by nonrandom 
withdrawal of less healthy participants.  This selection bias is a significant challenge in studies of 
older adults, often resulting in underestimated associations between a risk factor and outcome.  
Several analytic methods are recommended to evaluate the sensitivity of estimates to missing 
data in future studies of functional decline. 
Finally, as central arterial stiffness continues to emerge as an important determinant of 
functional decline and mortality in older adults, there is growing interest in potential 
interventions to slow or reverse vascular alterations associated with aging.  Hypertension, 
diabetes, and smoking each accelerate arterial stiffening independent of age; control of these 
modifiable risk factors are key strategies to promote successful aging.  Recently, 
antihypertensive agents which target the renin-angiotensin-aldosterone system have shown 
promise to reduce or reverse arterial stiffness independent of blood pressure.  Future work is 
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needed to clarify the contribution of these therapies to vascular health and disease risk 
independent of blood pressure lowering.  Now faced with growing burdens of chronic disease 
and disability, aging populations must recognize the devastating consequences of hypertension 
and underlying arterial stiffness.    
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Table 1. Studies of pulse wave velocity and cognitive function or decline 
Author Study Design Study Population Cognitive Assessment Results 
Hanon et al. (Hanon 
et al., 2005) France 
2005 
Cross-sectional 308 older adults attending 
outpatient clinic reporting 
memory impairment; age 78+/- 
8 yrs; 64% women 
MMSE PWV higher in dementia and MCI 
relative to no cognitive 
impairment (p<0.01) 
Scuteri et al. (Scuteri, 
Brancati, Gianni, 
Assisi, & Volpe, 
2005)  Italy 2005 
Cross-sectional 84 older adults referred for 
memory deficit; age 78+/-5 yrs; 
30 men, 40 women 
MMSE PWV inversely correlated with 
MMSE score (r=-0.26, p<0.05)  
Fujiwara et al. 
(Fujiwara et al., 
2005) Japan 2005 
Cross-sectional 352 adults age 70 and older 
participating in comprehensive 
health examination in April 
2003  
MMSE Poor cognitive function (MMSE < 
24) associated with PWV middle 
tertile (OR=9.66, 95% CI = 1.15 - 
80.93) 
Fukuhara et al.  
(Fukuhara et al., 
2006)  Japan 2006 
Cross-sectional 203 85-year old participants in 
health survey; 87 men, 116 
women 
MMSE PWV significantly higher in 
impaired MMSE group compared 
to normal MMSE group (p<0.05) 
Scuteri et al. (Scuteri 
et al., 2007)  Italy 
2007 
Prospective  102 older adults reporting 
memory problems; age 79 +/6 
years; 31 men, 71 women 
MMSE PWV predicted cognitive decline, 
explaining 15.2% of total variance 
(p<0.001) 
Poels et al. (Poels et 
al., 2007) 
Netherlands 2007 
Prospective  2767 adults age 55 and older 
participating in the Rotterdam 
Study   
MMSE, Letter-Digit 
Substitution, Stroop Test, 
Word Fluency Test 
Higher PWV associated with 
poorer performance on Stroop test 
(Beta [95% CI] = 1.13 [0.26 to 
1.99] per SD higher PWV) but not 
cognitive decline or incident 
dementia 
Muller et al. (Muller 
et al., 2007) 
Netherlands 2007 
Cross-Sectional 400 community-dwelling men 
aged 40-80 years 
MMSE, Rey test of 
auditory verbal learning, 
Doors test of visual 
memory, Digit Span, Trail 
Making Test, Digit 
Symbol Substitution 
Subjects with subclinical or 
prevalent CVD had lower MMSE 
scores compared to subjects 
without CVD (p=0.003) 
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Table 1 continued. 
 
Author 
 
Study Design 
 
Study Population 
 
Cognitive Assessment 
 
Results 
Waldstein et al. 
(Waldstein et al., 
2008) 
USA 2008 
Prospective 582 adults participating in the 
Baltimore Longitudinal Study of 
Aging (BLSA); age 54 +/- 17 
years; 44% men 
MMSE, Blessed I-M-C 
cognitive screening test, 
Digits Forward and 
Backward, California 
Verbal Learning Test, 
Benton Visual Retention 
Test, Trail Making Test, 
Letter and Category 
Fluency, Boston Naming 
Test 
Higher baseline PWV associated 
with greater decline in global 
cognitive function, learning, and 
memory, but not executive 
function or processing speed 
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2.1 ABSTRACT 
Background: In community-dwelling older adults global cognitive function predicts gait speed 
decline.  Whether specific cognitive deficits account for gait speed decline is unknown.  
Methods: Several cognitive domains were evaluated at baseline in 909 participants in the Health, 
Aging and Body Composition Study Cognitive Vitality Substudy (mean age 75.2 ± 2.8 years, 
50.6% women, 48.4% black).  Usual gait speed (m/s) over 20 m was assessed at baseline and 
over five-year follow-up.  Results: Poorer performance in each cognitive domain was cross-
sectionally associated with slower gait independent of demographic and health characteristics.  
In longitudinal analyses, each 1-SD poorer performance in global function, verbal memory and 
executive function was associated with 0.003-0.004 m/s greater gait speed decline per year 
(p=0.03-0.05) after adjustment for baseline gait speed, demographic and health characteristics.  
Conclusions: In this well-functioning cohort, several cognitive domains were associated with 
gait speed cross-sectionally and predicted longitudinal gait speed decline.  These data are 
consistent with a shared pathology underlying cognitive and physical declines but do not suggest 
that specific cognitive deficits account for gait slowing in aging. 
 
2.2 INTRODUCTION 
Many studies have identified an independent relationship of cognitive and physical performance 
in older adults.  While it is well-known that several cognitive processes are associated with 
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walking speed cross-sectionally (Ble et al., 2005; Holtzer et al., 2006; Rosano, Simonsick et al., 
2005), there is reason to hypothesize that impairment of attention and executive function may in 
part explain gait slowing with age (Coppin et al., 2006; Melzer & Oddsson, 2004; van Iersel, 
Kessels, Bloem, Verbeek, & Olde Rikkert, 2008).  Considered important for the planning and 
execution of movements, executive function and attention are mediated by frontal-subcortical 
circuits associated with mobility and balance (Blahak et al., 2009; Pugh & Lipsitz, 2002; Tekin 
& Cummings, 2002).  This extensive neural network is vulnerable to ischemic changes within 
the deep white matter (Kuo & Lipsitz, 2004), suggesting that cerebrovascular alterations in aging 
(Iadecola, Park, & Capone, 2009) may contribute to declines in executive and motor functions 
(Pugh & Lipsitz, 2002; Roriz-Cruz et al., 2007).   
In the Health, Aging and Body Composition (Health ABC) study, poorer global and 
executive function were associated with accelerated gait speed decline over three years 
(Atkinson et al., 2007); conversely, gait speed at baseline predicted decline in attention and 
psychomotor speed over five years (Inzitari, Newman et al., 2007).  These findings are consistent 
with a shared etiology of cognitive and physical decline (Pugh & Lipsitz, 2002) and further 
suggest that executive and psychomotor deficits may manifest in gait slowing (Soumare, 
Tavernier, Alperovitch, Tzourio, & Elbaz, 2009), even before such deficits can be detected 
(Inzitari, Newman et al., 2007).  It is unclear whether an association of cognitive function with 
gait decline exists across multiple cognitive processes or is restricted to a few specific domains.    
We evaluated the relationship of cognitive function with usual gait speed at baseline and 
over five years in the Health ABC Cognitive Vitality Substudy, in which participants completed 
a detailed assessment of memory and other specific domains not evaluated in the full Health 
ABC cohort.  Cross-sectional associations of cognitive and gait performance in this analysis 
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would support a shared pathology underlying cognitive and physical declines in aging.  Further, 
associations of specific cognitive domains with gait speed decline would suggest that deficits in 
these domains may in part account for gait slowing in older adults.     
2.3 METHODS 
2.3.1 Population 
From 1997 to 1998 the Health ABC study enrolled 3,075 Medicare-eligible well-functioning 
men and women aged 70-79 from Pittsburgh, Pa. and Memphis, Tn., USA.  The population was 
52% women and 42% black with a mean age of 73.6 years.  Participants were recruited from 
Medicare-eligible adults with contact information provided by the Centers for Medicare & 
Medicaid Services (formerly the Health Care Financing Administration) on a random sample of 
white and all black beneficiaries in pre-designed zip code areas surrounding the study centers.  
Other household members aged 70-79 were also eligible for recruitment.  Exclusion criteria 
included reported difficulty walking one quarter of a mile, climbing 10 steps without resting, or 
performing basic activities of daily living or need for a walking aid.   
In Year 3 of Health ABC, the Cognitive Vitality Substudy was initiated.  Participants 
represent approximately the top 20% of performers on an endurance walk test (Simonsick, 
Montgomery, Newman, Bauer, & Harris, 2001) in Year 2 from each of eight groups defined by 
sex, race, and study site (Memphis or Pittsburgh) and an equal number drawn at random from the 
remaining members of each group yielding 951 black and white women and men aged 72-81 
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years who received additional cognitive testing.  Substudy participants were slightly younger 
(75.5 years versus 75.7 years) and more likely to be white (65% versus 55%) compared to the 
Health ABC participants who were not part of the substudy.  Exclusion criteria included self-
reported difficulty seeing large print or grasping a pen.  The Institutional Review Boards of the 
University of Pittsburgh, Pa., and University of Tennessee at Memphis approved the study, and 
written, informed consent was obtained from each volunteer.  Of the 951 participants in the 
substudy, 920 completed cognitive and gait speed testing at Year 3.  Of these participants, we 
excluded those with either lower extremity revascularization (n=8) or angioplasty (n=3), leaving 
909 participants for cross-sectional analyses (mean age 75.2 ± 2.8 years, 50.6% women, 48.4% 
black).  Longitudinal analyses included 865 participants who also had at least one gait speed 
measurement over the subsequent five-year period (mean age 75.2 ± 2.8 years, 50.5% women, 
47.5% black).   
2.3.2      Cognitive Tests 
 Cognitive function was assessed at baseline of the substudy (Year 3).  The Modified Mini-
Mental Status Exam (3MS) (Teng & Chui, 1987) is a comprehensive evaluation of global 
cognitive function, including orientation, attention, calculation, language and short-term 
memory.  Scores can range from 0 to 100 points, with lower scores indicating poorer 
performance.  The Buschke Selective Reminding Test (SRT) (Buschke & Fuld, 1974) is a 
multiple-trial list-learning task used to measure verbal learning and memory.  In this task, the 
examiner presents a list of 12 written words and reads each word aloud.  The participant is then 
asked to recall the words presented.  For the next trial, the examiner repeats the words the 
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participant failed to recall and then asks the participant to provide the full list of 12 words. This 
procedure is repeated five times.  Long-term storage is scored as the number of words recalled at 
least twice in a row that were also recalled in Trial 6.  The 15-item Executive Interview (EXIT 
15) was developed for the Health ABC study and constitutes a shortened version of the 25-item 
Executive Interview (Royall, Mahurin, & Gray, 1992).  The test assesses several executive 
control functions such as inhibition of automatic responses, word and design fluency, and 
sequencing, and is scored from 0 to 30, with lower scores indicating better performance.  The 
Boxes and Digit Copying (BDC) tests are timed tests of attention and psychomotor speed 
(Salthouse, 1996).  The participant is asked to complete as many boxes and copy as many digits 
as possible within 30 seconds for each test.  Psychomotor speed is scored as the sum of total 
boxes and digits completed (rho = 0.77).  Finally, the Pattern and Letter Comparison (PLC) tests 
are timed tests of attention and perceptual speed (Salthouse, 1996).  The participant is asked to 
determine whether pairs of patterns and letters are the same or different within 30 seconds for 
each test.  Perceptual speed is scored as the sum of correct pattern and letter comparisons 
(rho=0.64).   
2.3.3      Gait Speed  
Gait speed was measured as the time needed to walk a 20-meter straight course at usual pace.  
Timing began at the first footfall over the starting line and ended with the first footfall over the 
finishing line.  This analysis includes up to five measurements of gait speed collected Years 3-6 
and Year 8 in Health ABC.   
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2.3.4      Covariates  
We considered as covariates variables that were identified in the literature as potential 
confounders of the relationship between cognitive function and gait speed, or were associated 
with both cognitive function and gait speed in this cohort with a p-value <0.15.  Selected 
covariates included demographic variables (age, race, sex, education and clinic site), vascular 
risk factors (body mass index (BMI), smoking, and physical activity), depressive symptoms and 
chronic conditions (prevalent coronary heart disease, cerebrovascular disease, hypertension, 
diabetes mellitus, and peripheral arterial disease).  Presence of chronic conditions was 
determined from participant reports at the baseline visit.  Depressive symptoms were assessed 
using the Centers for Epidemiologic Studies of Depression 10-item scale (CESD-10) (Andresen, 
Malmgren, Carter, & Patrick, 1994).  BMI was calculated as measured weight in kilograms 
divided by measured height in meters squared.  Walking frequency and duration was determined 
from responses to questions which distinguished walking for exercise and other types of walking 
from a standardized, interviewer-administered physical activity battery (Brach, Simonsick, 
Kritchevsky, Yaffe, & Newman, 2004).  Participants walking a total of <30 minutes per week 
were defined as sedentary.  Finally, ankle-arm index was calculated as the ratio of the systolic 
blood pressure obtained in the ankle to the systolic blood pressure of the right arm.  Measures 
were performed twice and the results were averaged; the lower average value between the two 
legs was used to define an individual’s ankle-arm index.  Peripheral arterial disease was then 
defined as ankle-arm index less than or equal to 0.9, according to traditional diagnostic criteria 
(Yao, Hobbs, & Irvine, 1969).  
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2.3.5      Statistical Analysis 
Differences in baseline characteristics across quartiles of gait speed and cognitive function were 
tested with Chi-square tests for categorical variables and analysis of variance or Kruskal-Wallis 
tests for continuous variables.  Associations between cognitive domains were evaluated using 
Pearson correlations adjusted for demographics.  Linear regression was used to test the cross-
sectional association between cognitive function as the independent variable and gait speed as 
the dependent variable adjusting for demographics, risk factors, depressive symptoms and 
chronic conditions.  Cognitive scores were standardized to allow direct comparison of regression 
coefficients.  Multivariable models were built using a backward procedure (p out=0.5) after 
entering in cognitive test score and demographics. Low values of the variance inflation factor 
(<2) excluded the risk of multicollinearity.   
Because patterns of specific cognitive deficits differ in normal aging and dementia 
(Buckner, 2004), we tested interactions between each cognitive test and cognitive status, 
categorized as normal cognitive function vs. cognitive impairment or decline.  For these 
analyses, cognitive impairment was defined as a 3MS score less than 80 at Year 3, and cognitive 
decline as a decrease in 3MS score of 5 or more points from Year 1 to Year 3.  
Linear mixed-effects models were used to evaluate associations of cognitive performance 
with the rate of gait speed decline over five years.  A simple model for each cognitive domain 
included a random intercept for each subject, a random slope for time, baseline gait speed and 
demographics as fixed effects, and interaction terms for baseline cognitive score and covariates 
with time.  Full models were built using a backward procedure (p out = 0.05) to additionally 
adjust for vascular risk factors and chronic conditions and the interactions of each covariate with 
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time.  No structure was imposed on the covariance matrix of the random effects.  Analyses were 
performed in Stata 10 (STATA, Houston, TX).  
Finally, we used random-effects pattern mixture models (Hedeker & Gibbons, 1997) to 
evaluate the influence of missing gait speed data at final follow-up (n=303; 33.3%) in the 
analysis of gait speed decline.  This method involves stratifying participants by their missing 
data pattern, then evaluating the influence of each missing data pattern on the outcome of 
interest.  The results of the pattern-mixture model may then be averaged over the missing data 
patterns to obtain overall estimates that are corrected for missing data patterns.  We performed 
these analyses using adapted code (Hedeker & Gibbons, 1997) in SAS 9 (SAS Institute, Inc., 
Cary, NC).  
2.4 RESULTS 
Mean age of the cohort was 75.2 years (SD 2.8); 49.4% were men and 48.4% black (Table 2).  
Mean gait speed at baseline was 1.20 (SD 0.22) m/s.  Participants in lower quartiles of gait speed 
were more likely to be female, black, sedentary, and have less education, higher BMI, chronic 
conditions and poorer performance on all cognitive tests (Tables 2 and 3).  Cognitive domains 
showed low to moderate correlation with each other after adjustment for demographics (Table 4). 
In separate linear regression models of each cognitive test, poorer performance in each 
test (SD) was significantly associated with slower gait speed after adjustment for demographics, 
risk factors and chronic conditions (Table 5).  Interaction terms for each cognitive test and 
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cognitive status were nonsignificant.  In analyses excluding participants with cognitive 
impairment or decline, associations were similar to those observed in the whole sample.   
In separate mixed models of each cognitive domain and gait speed decline, each 
interaction term for cognitive test score and time represents the calculated contribution of 
cognitive score to the rate of gait speed decline per year (Table 6).  Each 1-SD poorer 
performance in global function, verbal memory and executive function was associated with 
0.003-0.004 m/s greater gait speed decline per year (p=0.03-0.05) after adjustment for baseline 
gait speed, demographic and health characteristics.  Psychomotor and perceptual speed 
performances were not significantly associated with rate of gait speed decline in simple or full 
models.       
Pattern-mixture models of gait speed decline indicated that participants who did not 
complete gait speed testing at final follow-up had significantly slower gait and faster gait speed 
decline relative to completers.   However, interactions of cognitive test score with time did not 
vary among completers and non-completers.  Overall estimates for these interaction terms were 
similar to estimates from mixed models.   
2.5  DISCUSSION 
In this community-dwelling cohort, poorer performances in several cognitive domains were 
associated with slower gait speed cross-sectionally and predicted gait speed decline over five 
years.  These results are consistent with a shared pathology underlying cognitive and physical 
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declines but do not suggest that specific cognitive deficits account for gait speed decline in 
aging. 
Previous analyses in Health ABC found relationships of poorer psychomotor speed and 
executive function with slower gait or accelerated gait speed decline (Atkinson et al., 2007; 
Rosano, Simonsick et al., 2005), providing support to the hypothesis that compromised attention 
and executive function may be particularly important to explain gait slowing with age.  However, 
in this analysis of participants who completed additional, detailed cognitive assessments, we 
identified similar associations with gait speed decline across global function, memory and 
executive function, suggesting that relationships between cognitive and physical function in 
aging are not restricted to specific cognitive domains. 
Considered evidence of cerebral small vessel injury related to hypertension (Longstreth et 
al., 1996; Ovbiagele & Saver, 2006), hyperintensities of white matter tracts seen on brain MRI 
preferentially influence frontal-subcortical circuits that mediate executive and motor functions 
(Prins et al., 2005; Pugh & Lipsitz, 2002), although multiple cognitive domains, including 
memory, may be affected (de Groot et al., 2000).  White matter hyperintensities predict gait 
speed decline (Rosano, Kuller et al., 2005), physical disability (Sachdev, Wen, Christensen, & 
Jorm, 2005) and functional limitation (Rosano, Kuller et al., 2005), suggesting underlying 
microvascular abnormalities may explain associations of several cognitive domains with gait 
speed decline.  Although brain imaging data were not available to test this hypothesis in this 
cohort, we identified BMI, physical activity, cerebrovascular disease, diabetes, hypertension and 
peripheral arterial disease as important covariates in cross-sectional analyses of each cognitive 
test and gait speed, consistent with a shared vascular contribution to age-associated cognitive and 
physical declines. 
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Similar to our findings, poorer global and executive function in the full Health ABC 
cohort (Atkinson et al., 2007) and verbal fluency, involving memory, executive and processing 
speed components, in the Three-City Study (Soumare et al., 2009) were associated with 
accelerated gait speed decline.  Although we did not identify an association of psychomotor or 
perceptual speed with rate of gait speed decline, in the Three-City Study poorer performance on 
the Trail Making Test part A (TMT-A) (Reitan, 1958), a test of psychomotor speed, was 
associated with greater gait speed decline after seven years.  The inconsistent findings may 
reflect the exceptional functional status of substudy participants or sensitivity of the TMT-A to 
subtle psychomotor deficits.  Additionally, this analysis may be limited by nonrandom 
withdrawal of substudy participants with chronic conditions, in that persons experiencing the 
greatest declines in gait speed may have been unable to continue study participation.  However, 
pattern-mixture models of gait speed decline did not suggest that estimated contributions of 
cognitive function to gait speed decline are sensitive to missing data.   
Additional limitations should be considered.  First, some components of the cognitive 
tests required motor skills (e.g. drawing and copying figures), possibly obscuring the distinction 
between cognitive and physical function.  Second, the potential influence of executive function 
on mobility may best be evaluated under challenging conditions that represent unpredictable 
environments in daily life [4].  In additional cross-sectional analyses of cognitive performance 
and gait speed at fast pace, the association of executive function with this task condition was 
substantially strengthened, possibly reflecting a higher demand of attention in the fast relative to 
usual pace walk (Fitzpatrick et al., 2007).   
Finally, strengths of our study include the large community-dwelling population, 
assessment of memory and other specific cognitive domains, ability to account for several 
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potential confounders, and repeated assessments of gait speed, a reliable and valid measure of 
physical function that predicts functional limitation (Cesari et al., 2005; Guralnik et al., 2000) in 
older adults.           
2.6 CONCLUSION 
Several specific cognitive domains were associated with gait speed cross-sectionally and 
predicted gait speed decline in this well-functioning cohort.  These findings are consistent with a 
shared etiology of cognitive and physical declines but do not suggest that deficits in specific 
cognitive domains account for gait slowing in aging.  More work is needed to evaluate the 
potential role of vascular disease in dysfunction of both systems; MRI studies of cerebral small-
vessel disease may clarify the mechanisms underlying co-occurring declines in cognitive and 
physical performance.  Further understanding of these pathways may provide targeted strategies 
to preserve function in both central facets of successful aging. 
 
 
 
 
 
 
 
 
Table 2. Characteristics of the cohort by quartiles (range in parentheses) of baseline gait speed (m/s) 
 
                            Mean ± SD, Median (IQR) or %  
 
 
 
 
Overall 
(0.47-1.93) 
  
n = 909 
 
Q1 
(<1.05) 
 
n = 228 
 
Q2 
(1.05-1.21)  
 
n = 229 
 
Q3 
(1.21-1.36)  
 
n=226 
 
Q4 
(≥1.36) 
 
n=226 
 
p 
Age, years 
 
75.2 ± 2.8 75.8 ± 2.9 75.1 ± 2.8 75.2 ± 2.7 74.7 ± 2.5 <0.001 
Male % 
 
49.4 36.4 49.8 51.8 59.7 <0.001 
Black % 
 
48.4 73.3 59.4 38.1 22.6 <0.001 
Education ≥ 12 yr % 
 
78.4 65.2 72.4 86.2 89.8 <0.001 
BMI, kg/m2 
 
26.9 ± 4.6 28.5 ± 5.7 26.8 ± 4.3  26.6 ± 4.2 25.6 ± 3.3 <0.001 
Current or former smoker % 52.2 47.8 53.7 51.8 55.6 0.391 
Sedentary % 68.2 83.7 71.5 62.5 54.7 <0.001 
Coronary heart disease % 17.1 20.0 16.1 16.9 15.5 0.594 
Cerebrovascular disease % 6.2 9.8 7.1 4.4 3.6 0.026 
Diabetes % 
 
19.5 31.3 21.8 12.4 12.4 <0.001 
Hypertension % 
 
 
59.4 78.5 60.7 53.1 45.1 <0.001 
CES-D 10 3 (5) 4 (5) 3 (5) 3 (4) 3 (4) <0.001* 
Ankle arm index < 0.9 % 13.9 26.0 15.3 7.1 7.1 <0.001 
P-values are from Chi-square tests of proportions for categorical variables and analysis of variance for comparison of mean values 
of continuous variables, unless otherwise noted. 
*Kruskal-Wallis test of equal medians 
CES-D 10 = Centers for Epidemiologic Studies of Depression 10-item scale 
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Table 3. Cognitive performance by quartiles (range in parentheses) of baseline gait speed (m/s) 
 
Mean ± SD or Median (IQR) 
 
 
 
Overall 
(0.47-1.93) 
 
n = 909 
 
Q1 
(<1.05) 
 
n = 228 
 
Q2 
(1.05-1.21) 
 
n = 229 
 
Q3 
(1.21-1.36) 
 
n=226 
 
Q4 
(≥1.36) 
 
n=226 
 
p 
 
Global function 
 
90.2 ± 7.9 89 (12) 90 (10) 94 (9) 95 (6) <0.001* 
Verbal memory 
 
6.6 ± 3.0 5.6 ± 3.0 6.3 ± 2.8 7.0 ± 2.9 7.5 ± 2.9 <0.001 
Executive function 
 
6.3 ± 4.2 8 (6) 6 (5) 5 (6) 4 (5) <0.001* 
Psychomotor speed 
 
 
76.5 ± 20.6 66.0 ± 19.1 72.0 ± 20.0 79.6 ± 18.9 88.6 ± 16.9 <0.001 
Perceptual speed 15.6 ± 5.4 13.3 ± 5.3 14.5 ± 5.2 16.4 ± 5.2 18.2 ± 4.6 <0.001 
 
P-values are from analysis of variance for comparison of mean values of continuous variables, unless otherwise noted. 
*Kruskal-Wallis test of equal medians 
 
 
 
Table 4. Partial correlation coefficients* between cognitive domains at baseline 
 
 Global function Verbal memory Executive 
function 
Psychomotor 
speed 
Perceptual 
speed 
Global function --- 0.44 0.54 0.31 0.36 
Verbal memory 0.44 --- 0.27 0.21 0.26 
Executive function 0.54 0.27 --- 0.32 0.39 
Psychomotor speed 0.31 0.21 0.32 --- 0.58 
Perceptual speed 0.36 0.26 0.39 0.58 --- 
 
p<0.001 for all 
*adjusted for age, sex, race, education and clinic site 
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Table 5. Coefficients with SE in parentheses fr om m ultivariable linea r reg ression mo dels of ba seline ga it 
speed (m/s) 
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Model 1 adjusted for age, sex, race, education and clinic site 
Model 2 additionally adjusted for body mass index, smoking status, and physical activity  
Model 3 additionally adjusted for depressive symptoms, coronary heart disease, cerebrovascular disease, diabetes mellitus, 
hypertension, and peripheral arterial disease  
 
 
 
Table 6. Calculated contribution of a 1-SD lower cognitive performance to decline in gait speed (m/s) per year 
 
Model 1  Model 2  Model 3  
Cognitive Measure 
(SD) Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Global function (7.6) 
 
0.003 (0.002) 0.04 0.003 (0.002) 0.03 0.003 (0.002) 0.03 
Verbal memory (3.0) 
 
0.004 (0.001) 0.01 0.004 (0.001) 0.03 0.004 (0.001) 0.03 
Executive function (4.0) 
 
0.003 (0.001) 0.04 0.003 (0.001) 0.04 0.003 (0.001) 0.05 
Psychomotor speed (20.4) 
 
0.002 (0.002) 0.29 0.002 (0.002) 0.27 0.002 (0.002) 0.32 
Perceptual speed (5.3) 
 
0.001 (0.001) 0.57 0.001 (0.001) 0.55 0.001 (0.001) 0.60 
 
Model 1 adjusted for age, sex, race, education, clinic site, baseline gait speed, and interaction of each covariate with time 
Model 2 additionally adjusted for body mass index, smoking status, physical activity, and interaction of each covariate   with time 
Model 3 additionally adjusted for depressive symptoms, coronary heart disease, cerebrovascular disease, diabetes mellitus, 
hypertension, peripheral arterial disease, and interaction of each covariate with time 
 
Model 1  Model 2  Model 3  
Cognitive Measure 
(SD) Beta (SE) p Beta (SE) p Beta (SE) p 
Global function (7.9) 
 
0.032 (0.008) <0.001 0.037 (0.008) <0.001 0.031 (0.008) <0.001 
Verbal memory (3.0) 
 
0.027 (0.007) <0.001 0.026 (0.007) <0.001 0.021 (0.007) 0.002 
Executive function (4.2) 
 
0.030 (0.008) <0.001 0.032 (0.008) <0.001 0.021 (0.008) 0.007 
Psychomotor speed (20.6) 
 
0.056 (0.008) <0.001 0.056 (0.007) <0.001 0.048 (0.007) <0.001 
Perceptual speed (5.4) 
 
0.036 (0.008) <0.001 0.038 (0.007) <0.001 0.029 (0.007) <0.001 
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3.1 ABSTRACT 
Objective: To evaluate associations of central arterial stiffness with cognitive function and 
decline in several specific cognitive domains in an older community-based population.  Design: 
Observational cohort study.  Setting: Five hundred fifty-two participants in the Health, Aging 
and Body Composition (Health ABC) study Cognitive Vitality Substudy (mean age ± SD 73.1 ± 
2.7 years, 48% men, 42% black).  Measurements: Pulse wave velocity (PWV) (cm/s), a measure 
of aortic stiffness, was assessed at baseline via Doppler-recorded carotid and femoral pulse 
waveforms.  Multiple cognitive domains were evaluated over six years.  Results: After 
adjustment for demographics, vascular risk factors and chronic conditions, each 1-SD higher 
PWV (389 cm/s) was associated with poorer cognitive function: -0.11 SD for global function 
(SE = 0.04, p < 0.01); -0.09 SD for psychomotor speed (SE = 0.04, p = 0.03), and -0.12 SD for 
perceptual speed (SE = 0.04, p < 0.01).  Higher PWV was also associated with greater decline in 
psychomotor speed, defined as >1 SD more than the mean change (OR 1.42 (95% CI 1.06, 1.90)) 
but not with verbal memory or longitudinal decline in global function, verbal memory or 
perceptual speed.  Results were consistent with mixed models of decline in each cognitive test.  
Conclusions: Central arterial stiffness may contribute to cognitive decline independent of 
hypertension and other vascular risk factors.  Frontal and subcortical regions that mediate 
psychomotor speed may be particularly vulnerable to cerebrovascular injury in the presence of 
arterial stiffness. 
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3.2 INTRODUCTION 
Vascular risk factors are important predictors of cognitive decline and dementia (Breteler, 2000; 
de la Torre, 2002).  Independent of traditional risk factors, arterial stiffness is associated with 
cerebral microvascular disease (Henskens et al., 2008; Kearney-Schwartz et al., 2009; Ohmine et 
al., 2008) commonly detected on brain MRI in older adults as hyperintensities of white matter 
tracts (Manolio et al., 1994).  This relationship has been attributed to the exposure of fragile 
cerebral small vessels to damaging central pulse pressures that are transmitted, rather than 
cushioned, by stiffened vessels (Mitchell, 2008; O'Rourke & Safar, 2005).  Small-vessel disease 
in the brain preferentially affects frontal-subcortical regions that mediate executive and motor 
functions (Buckner, 2004; Pugh & Lipsitz, 2002), suggesting that arterial stiffness may 
contribute to decline in these specific cognitive domains. 
Several studies have found elevated pulse wave velocity (PWV), a measure of central 
arterial stiffness, cross-sectionally associated with poorer cognitive function in older adults (Elias 
et al., 2009; Fujiwara et al., 2005; Fukuhara et al., 2006; Scuteri et al., 2005; Triantafyllidi et al., 
2009).  Associations of PWV with cognitive decline over time are less consistent.  Elevated 
PWV did not predict decline in either global cognitive function, verbal fluency, executive 
function or processing speed in the Rotterdam study (mean age 72 years) (Poels et al., 2007); 
however, in an analysis of the Baltimore Longitudinal Study of Aging (BLSA) (mean age 54 
years) (Waldstein et al., 2008) higher PWV was associated with accelerated decline in learning 
and memory.  Findings from BLSA may reflect a contribution of arterial stiffness and associated 
central pressures to cognitive decline in mid to late life. 
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To clarify the association of central arterial stiffness with cognitive decline in aging, we 
evaluated the relationships of PWV with global cognitive function and performance in several 
cognitive tasks over six years in the Health, Aging and Body Composition (Health ABC) 
Cognitive Vitality Substudy.  This study extends on previous work by characterizing associations 
of PWV with longitudinal cognitive decline among older adults who were initially free of 
functional limitation. 
3.3 METHODS 
3.3.1 Population 
From 1997 to 1998 the Health ABC study enrolled 3,075 Medicare-eligible well-functioning 
men and women aged 70-79 from Pittsburgh, Pa. and Memphis, Tn., USA.  The population was 
52% women and 42% black with a mean age of 73.6 years.  Participants were recruited from 
Medicare-eligible adults with contact information provided by the Centers for Medicare & 
Medicaid Services (formerly the Health Care Financing Administration) on a random sample of 
white and all black beneficiaries in pre-designed zip code areas surrounding the study centers.  
Other household members aged 70-79 were also eligible for recruitment.  Exclusion criteria 
included reported difficulty walking one quarter of a mile, climbing 10 steps without resting, or 
performing basic activities of daily living or need for a walking aid.   
In Year 3 of Health ABC, the Cognitive Vitality Substudy was initiated.  Participants 
were selected from the top 20% of performers on an endurance walk test (Simonsick et al., 2001) 
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in Year 2 from each of eight groups defined by sex, race, and study site (Memphis or Pittsburgh).  
An equal number were then drawn at random from the remaining members of each group 
yielding 951 black and white women and men aged 71-82 years who received additional 
cognitive testing.  Substudy participants were slightly younger (75.5 years versus 75.7 years), 
more likely to be female (54% versus 50%) and white (65% versus 55%) and have <12 years 
education (30% versus 23%) compared to the Health ABC participants who were not part of the 
substudy.  Substudy exclusion criteria included self-reported difficulty seeing large print or 
grasping a pen.  The Institutional Review Boards of the University of Pittsburgh, Pa., and 
University of Tennessee at Memphis approved the study, and written, informed consent was 
obtained from each volunteer.  Of the 951 participants in the substudy, 727 had valid PWV data 
at baseline and cognitive data at Year 3.  Of the 727 participants, we excluded those with 
evidence of cognitive impairment at Year 3 (Teng-modified Mini-Mental Status Exam (3MS) 
score less than 80; N = 75) or decline prior to Year 3 (decrease in 3MS score of 5 or more points; 
N = 100), leaving 552 participants for analysis (mean age 73.1 ± 2.7 years, 48% men, 42% 
black).   
3.3.2 Pulse wave velocity 
Aortic PWV was measured noninvasively via simultaneous Doppler-recorded carotid and 
femoral pulse waveforms (model 810A, 9.0- to 10-MHz probes, Parks Medical Electronics, Inc).  
A minimum of ten beats were recorded for each simultaneous recording site.  Three separate runs 
were recorded for each participant, and all usable runs were averaged to calculate the final PWV 
measure.  The distance between the carotid and femoral recording sites was measured above the 
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surface of the body with a tape measure.  The time delay between the feet of the pressure waves 
at each site was divided by the associated distance to calculate PWV in cm/s.  Replicate 
measures of PWV in 14 subjects revealed intraclass correlations of 0.88 between sonographers 
and 0.84 between readers (Sutton-Tyrrell et al., 2005). 
3.3.3 Cognitive Tests 
Cognitive function was assessed at Years 3, 5, 7, and 9.  The Modified Mini-Mental Status Exam 
(3MS) (Teng & Chui, 1987) is a comprehensive evaluation of global cognitive function, 
including orientation, attention, calculation, language and short-term memory.  Scores can range 
from 0 to 100 points, with lower scores indicating poorer performance.  The Buschke Selective 
Reminding Test (SRT) (Buschke & Fuld, 1974) is a multiple-trial list-learning task used to 
measure verbal learning and memory.  In this task, the examiner presents a list of 12 written 
words and reads each word aloud.  The participant is then asked to recall the words presented.  
For the next trial, the examiner repeats the words the participant failed to recall and then asks the 
participant to provide the full list of 12 words. This procedure is repeated five times.  Delayed 
recall is scored as the number of words recalled 20-30 minutes after the sixth trial.  The Boxes 
and Digit Copying (BDC) tests are timed tests of psychomotor speed (Salthouse, 1996).  The 
participant is asked to complete as many boxes and copy as many digits as possible within 30 
seconds for each test.  Psychomotor speed is scored as the sum of total boxes and digits 
completed (rho = 0.77).  Finally, the Pattern and Letter Comparison (PLC) tests are timed tests of 
perceptual speed (Salthouse, 1996).  The participant is asked to determine whether pairs of 
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patterns and letters are the same or different within 30 seconds for each test.  Perceptual speed is 
scored as the sum of correct pattern and letter comparisons (rho = 0.64). 
3.3.4 Covariates 
We considered as covariates variables that were identified in the literature as potential 
confounders of the relationship between arterial stiffness and cognitive function, or were 
associated with both baseline PWV and Year 3 3MS score in this cohort at a significance level of 
0.15.  Selected covariates included demographic variables (age, race, sex, education (years of 
school, ≤12 years versus >12 years) and clinic site), risk factors (body mass index (BMI), history 
of smoking, physical activity, total cholesterol, resting heart rate, mean arterial pressure and 
depressive symptoms), and comorbid conditions (prevalent hypertension, coronary heart disease, 
cerebrovascular disease and diabetes mellitus).  All covariates were obtained from the baseline 
visit with the exception of depressive symptoms, which were evaluated at Year 3.  BMI was 
calculated as measured weight in kilograms divided by measured height in meters squared.  
Physical activity was assessed by questionnaire and used to calculate the kilocalories expended 
for all forms of walking and exercise, stair climbing and vigorous activity in the previous week; 
participants with at least 1,000 kcal expended were defined as active.  Total cholesterol was 
determined from fasting blood samples collected at the baseline clinic visit.  Systolic and 
diastolic blood pressures were each measured twice and averaged; mean arterial pressure was 
calculated as diastolic pressure + 1/3 (systolic pressure – diastolic pressure).  Depressive 
symptoms were assessed using the Centers for Epidemiologic Studies of Depression 10-item 
scale (CES-D) (Andresen et al., 1994).  Presence of hypertension and other conditions at baseline 
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was determined from participant reports of diagnosis and use of specific medications or 
procedures.   
3.3.5 Statistical Analysis 
Differences in baseline characteristics across tertiles of PWV and 3MS score were tested with 
Chi-squared tests for categorical variables and analysis of variance or Kruskal-Wallis tests for 
continuous variables.  Separate linear regression models were used to evaluate the association 
between PWV as the independent variable and performance on each cognitive test as the 
dependent variable.  In these models, scores for each cognitive test were standardized to allow 
for direct comparison of regression coefficients.  Logistic regression was used to test the 
association of PWV with cognitive decline, defined as 5 points or more decline on the 3MS 
(Andrew & Rockwood, 2008), and >1 SD more than the mean change on the SRT, BDC and 
PLC from Year 3 to Year 9.  Multivariate linear and logistic regression models were built using a 
backward procedure (p out = 0.05) to adjust for vascular risk factors and comorbid conditions 
after entering in PWV and demographics. 
Because the relationship of hypertension with cognitive decline may differ in normal 
aging and preclinical dementia, we repeated logistic regression models of cognitive decline after 
including in the sample participants with evidence of cognitive or impairment or decline at Year 
3 (n=175).  These analyses tested interactions of PWV and cognitive status, categorized as 
normal cognitive function versus cognitive impairment or decline.   
Finally, mixed models were used to confirm the associations of PWV with decline in 
each cognitive test.  The models included as outcomes all cognitive data available throughout the 
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study period, improving statistical power and reducing potential bias due to nonrandom 
censoring, relative to logistic regression models.  To account for an apparent learning effect in 
the verbal memory test from Year 3 to Year 5, models of decline in this test were restricted to 
Years 5, 7, and 9.  Simple models of decline in each cognitive test included a random intercept 
for subject, a random slope with time, and clinic site, PWV and the interaction of PWV with time 
as fixed effects.  A second model additionally adjusted for demographics and the interactions of 
each covariate with time.  Full models were built using a backward procedure (p out = 0.05) to 
additionally adjust for vascular risk factors and comorbidities and the interactions of each 
covariate with time.  No structure was imposed on the covariance matrix of the random effects.  
Continuous covariates were centered to reduce multicollinearity and simplify interpretation of 
model coefficients.  Analyses were performed in SAS (version 9.1; SAS Institute, Inc., Cary, 
NC) and Stata 10 (STATA, Houston, TX). 
3.4 RESULTS     
Mean age (SD) of this cohort at baseline was 73.1 (2.7) years; 48% were men and 42% black.  
Mean (SD) PWV was 886 (389) cm/s.  Participants with higher PWV were more likely to be 
black, hypertensive, less active, and have higher BMI, heart rate, and mean arterial pressure 
(Table 7).  In linear regression models adjusted for demographics, higher PWV at baseline was 
significantly associated with poorer performance on tests of global cognitive function, 
psychomotor speed and perceptual speed but not verbal memory.  Further adjustment for risk 
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factors and comorbidities in the backward procedure did not substantially change the coefficients 
for PWV in full models of each cognitive test (Table 8).  
Of the 552 participants in the sample, 406 completed cognitive testing at Year 9 and were 
included in logistic regression models of cognitive decline (mean age 73.0 ± 2.7 years, 47% men, 
42% black).  Cognitive decline >1 SD from the mean change related to a decline of ≥ 3 points on 
the SRT (n = 49); ≥ 20 on the BDC (n = 49); and ≥ 5 on the PLC (n = 68).  64 participants 
declined ≥ 5 points on the 3MS.  Fully adjusted, with each SD higher PWV the odds ratio 
increased by a factor of 1.42 for risk of decline in psychomotor speed (Table 9).  The association 
of PWV with psychomotor speed decline was attenuated (OR 1.10, 95% CI 0.82, 1.47) after 
inclusion of participants with evidence of cognitive impairment or decline at Year 3; however, 
interactions of PWV with cognitive status were nonsignificant.  PWV was not associated with 
risk of decline in global cognitive function, verbal memory, or perceptual speed in logistic 
regression models adjusted for demographics.   
Results of mixed models of cognitive decline in the full sample were consistent with 
results of logistic regression models (Table 10).  Fully adjusted, the calculated contribution of 
each SD higher PWV to psychomotor speed decline was modest though statistically significant: 
0.298 points per year (95% CI 0.099, 0.498).  PWV was not associated with decline in global 
cognitive function, verbal memory, or perceptual speed in mixed models adjusted for 
demographics. 
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3.5 DISCUSSION 
In this cohort of community-dwelling older adults, higher PWV was associated with poorer 
performance on tests of global cognitive function, psychomotor speed and perceptual speed and 
with decline in psychomotor speed after six years.  PWV was not associated with verbal memory 
or decline in global function, verbal memory or perceptual speed.  These data suggest that 
frontal-subcortical regions that mediate psychomotor speed may be particularly sensitive to 
central arterial stiffness.  
This study further investigates the recently identified inverse relationship of arterial 
stiffness with global cognitive function in older adults (Fujiwara et al., 2005; Fukuhara et al., 
2006; Scuteri et al., 2005).  The domain-specific associations in this cohort are consistent with a 
mediating role of cerebral small-vessel disease (Triantafyllidi et al., 2009), a common 
manifestation of ischemic injury that preferentially affects executive function and processing 
speed while sparing verbal memory (Jokinen et al., 2009; Prins et al., 2005).  Executive function 
and processing may be particularly vulnerable to vascular injury (Buckner, 2004; Pugh & 
Lipsitz, 2002) because much of the deep white matter is perfused by arterioles with few 
interconnections available to preserve blood supply in the presence of ischemic injury (Pantoni, 
2002). 
Although several studies of older adults have identified inverse associations between 
arterial stiffness and cognitive function cross-sectionally, few have evaluated the relationship of 
arterial stiffness with cognitive decline.  PWV did not predict cognitive decline in one recent 
study of community-dwelling older adults (Poels et al., 2007).  In another cohort, elevated PWV 
was associated with accelerated decline on tests of language and memory but not executive 
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function or psychomotor speed (Waldstein et al., 2008).  This pattern contrasts with our finding 
that elevated PWV predicted decline in psychomotor speed but not other cognitive domains.  
Inconsistent associations across studies may in part reflect important differences in selected 
cognitive assessments; for example, memory tasks that are more demanding of executive control 
and attention may be more sensitive to cerebrovascular changes in aging (Buckner, 2004).  
Further, in previous studies the contribution of arterial stiffness to cognitive decline in normal 
aging may have been partially obscured by the inclusion of participants with preclinical 
dementia. 
Several pathways have been hypothesized to link arterial stiffness with cerebral 
microvascular disease and cognitive function (Iadecola et al., 2009).  First, the loss of cushioning 
capacity of the stiffened aorta allows damaging central pulse pressures to be transmitted into the 
fragile small vessels of target organs (Mitchell, 2008; O'Rourke & Safar, 2005).  Highly pulsatile 
flow may accelerate the narrowing of the cerebral vasculature, impeding delivery of energy 
substrates and nutrients to active brain cells.  The resulting state of chronic hypoperfusion may 
directly injure cerebral white matter or allow toxic metabolic byproducts to accumulate within 
the brain and blood vessels (Iadecola et al., 2009).  Moreover, stiffening and thickening of the 
cerebral vasculature may contribute to endothelial dysfunction and associated breakdown of the 
blood-brain barrier.  Toxins, proteases, or other substances in the blood may then enter the brain 
interstitial space and injure surrounding neurons and glial cells (Wardlaw et al., 2003). 
Important limitations of this study should be considered.  Our analyses do not account for 
unmeasured progression of subclinical vascular disease from PWV assessment at baseline to 
cognitive assessment at Year 3.   Additionally, the estimated associations of PWV with cognitive 
decline may be sensitive to nonrandom withdrawal of participants who experienced the greatest 
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functional declines throughout the study period.  As expected, participants who completed final 
follow-up (n=406) were slightly younger at baseline (73.0 years versus 73.5 years) and less 
likely to have cerebrovascular disease (4% versus 8%) and hypertension (47% versus 58%) 
relative to noncompleters (n=146).  These limitations are expected to underestimate the 
associations of PWV with cognitive function and cognitive decline in the population.  Strengths 
of this study include the large community-dwelling population, assessment of function in 
specific cognitive domains, ability to account for important confounders, and a reliable and valid 
measure of arterial stiffness that predicts morbidity and mortality in older adults (Sutton-Tyrrell 
et al., 2005).           
In this initially well-functioning cohort, central arterial stiffness was inversely associated 
with performance in several cognitive tasks and predicted longitudinal decline in psychomotor 
speed independent of hypertension and other vascular risk factors.  Longitudinal brain imaging 
studies of older adults may clarify the spatial distribution of cerebrovascular injury in 
relationship to vascular stiffening.  Further work is needed evaluate whether reduction of central 
arterial stiffness and associated central pressures may reduce risk of cognitive decline beyond 
that expected by brachial blood pressure lowering.  As the cognitive consequences of arterial 
stiffening continue to emerge, strategies to combat this risky process of arterial aging should 
emphasize the long-term control of modifiable vascular risk factors. 
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Table 7. Baseline characteristics of the cohort by tertiles of PWV (cm/s) 
CES-D 10 = Center for Epidemiologic Studies Depression Scale; 3MS = Modified Mini-Mental Status Exam; SRT = Buschke  
Selective Reminding Test; BDC = Boxes and Digit Copying Tests; PLC = Pattern and Letter Comparison Tests 
P-values are from Chi-square tests of proportions for categorical variables and analysis of variance for comparison of mean 
values of continuous variables 
 
 
Characteristic 
 
 
(329-2823) 
 
(329-673) 
 
(673-925) 
 
(925-2823) 
 
p 
Age, yrs 73.1 ± 2.7 73.0 ± 2.5 73.1 ± 2.8 73.3 ± 2.7 0.28 
Male % 47.5 42.9 48.9 50.5 0.31 
Black % 42.2 35.3 44.6 46.7 0.06 
Education >12 yrs % 54.0 63.4 47.8 51.1 0.01 
BMI, kg/m2 27.0 ± 4.6 26.0 ± 4.0 27.6 ± 4.3 27.0 ± 4.6 <0.01 
Mean arterial blood pressure, 
mmHg
94.1 ± 12.3 90.2 ± 10.9 95.2 ± 11.8 96.9 ± 13.1 <0.01 
Cholesterol, mg/dl 202.7 ± 38.0 202.4 ± 33.8 205.1 ± 40.1 200.6 ± 39.8 0.53 
Heart rate, bpm 62.7 ± 10.6 61.0 ± 10.2 63.5 ± 11.2 63.7 ± 10.2 0.03 
Current or former smoker % 51.1 47.3 56.0 50.0 0.23 
Physical activity >1000 
kcal/wk %
45.1 51.6 45.7 38.0 0.03 
Hypertension % 50.0 33.7 52.8 63.6 <0.01 
Coronary heart disease % 14.8 12.6 15.4 16.4 0.58 
Cerebrovascular disease % 5.3 2.7 6.0 7.1 0.15 
Diabetes mellitus % 13.3 10.4 14.2 15.2 0.36 
CES-D 10 4.2 ± 3.8 4.2 ± 3.7 4.1 ± 3.8 4.3 ± 4.0 0.95 
Global cognitive function 
(3MS)
Perceptual speed (PLC) 
 
93.5 ± 4.9 94.4 ± 4.2 93.7 ± 5.1 92.3 ± 5.3 <0.01 
Verbal memory (SRT) 6.6 ± 3.0 6.7 ± 3.0 6.7 ± 3.0 6.3 ± 2.9 0.23 
Psychomotor speed (BDC) 80.9 ± 18.6 86.4 ± 17.3 79.6 ± 19.7 76.7 ± 17.5 <0.01 
16.7 ± 5.0 18.2 ± 4.6 16.2 ± 5.0 15.8 ± 5.0 <0.01 
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Model 1  
PWV Beta (95% CI) 
 
Model 2  
PWV Beta (95% CI) 
 
Model 3 
PWV Beta (95% CI) 
 
 
Co
 
Globa
 
 
gnitive Measure (SD) 
Cognitive Measure  
SDs* 
Cognitive Measure 
Original Units† 
Cognitive Measure  
SDs* 
Cognitive Measure 
Original Units† 
Cognitive Measure  
SDs* 
Cognitive Measure 
Original Units†  
l function (4.9) 
 
-0.17 (-0.25, -0.09) 
 
-0.82 (-1.24, -0.40) 
 
 
-0.11 (-0.19, -0.03) 
 
-0.53 (-0.89, -0.17) 
 
-0.11 (-0.19, -0.03) 
 
-0.55 (-0.91, -0.19) 
 
Verb
 
 
Psy
 
 
Percep
 
al memory (3.0) 
 
-0.09 (-0.17, -0.01) 
 
-0.26 (-0.52, 0.00) 
 
-0.06 (-0.14, 0.02) 
 
-0.17 (-0.41, 0.07) 
 
-0.07 (-0.15, 0.01) 
 
-0.20 (-0.44, 0.04) 
chomotor speed (18.6) 
 
-0.18 (-0.26, -0.10) 
 
-3.40 (-4.96, -1.84) 
 
-0.11 (-0.19, -0.03) 
 
-2.13 (-3.53, -0.73) 
 
-0.09 (-0.17, -0.01) 
 
-1.59 (-3.03, -0.15) 
tual speed (5.0) 
 
-0.18 (-0.26, -0.10) 
 
-0.90 (-1.32, -0.48) 
 
-0.12 (-0.20, -0.04) 
 
 
-0.61 (-0.97, -0.25) 
 
-0.12 (-0.20, -0.04) 
 
-0.60 (-0.98, -0.22) 
 
Mode
Mode
Mode
l 1 unadjusted 
l 2 adjusted for age, sex, race, education and clinic site 
l 3 additionally adjusted for body mass index, mean arterial pressure, cholesterol, heart rate, smoking status, physical activity, depressive 
symptom
* Bet
s, prevalent hypertension, coronary heart disease, cerebrovascular disease, and diabetes mellitus 
a= Δ SD’s of Cognitive Measure per SD of PWV 
 Beta= Δ Cognitive Measure (original units) per SD of PWV 
Table 8. Multivariable regression adjusted associations of 1-SD (389 cm/s) higher baseline PWV with lower Year 3 cognitive scores 
†
 
      Table 9. Risk of decline* in cognitive performance after six years, per SD (387 cm/s) higher baseline PWV 
 
Cognitive Measure  
 
Model 1  
OR (95%CI) 
Model 2  
OR (95%CI) 
Model 3 
OR (95%CI) 
 
Global function                
 
1.33 (1.05, 1.68) 
 
1.24 (0.96, 1.60) 
 
 
1.22 (0.90, 1.67) 
 
Verbal memory               
 
 
1.01 (0.75, 1.35) 
 
0.98 (0.71, 1.36) 
 
1.05 (0.74, 1.50) 
 
Psychomotor speed      
 
 
1.32 (1.02, 1.71) 
 
1.32 (1.01, 1.72) 
 
1.42 (1.06, 1.90) 
 
Perceptual speed           
 
 
0.99 (0.76, 1.29) 
 
0.96 (0.73, 1.26) 
 
0.97 (0.72, 1.31) 
 
Model 1 unadjusted 
Model 2 adjusted for age, sex, race, education and clinic site 
Model 3 additionally adjusted for body mass index, mean arterial pressure, cholesterol, heart 
rate, smoking status, physical activity, depressive symptoms, prevalent hypertension, coronary 
h
 
eart disease, cerebrovascular disease, and diabetes mellitus 
ction; ? 3 points in verbal memory; ? 20 points in 
psychomotor speed; ? 5 points n perceptual speed 
*Decline ? 5 points in global fun
odel  j st   
odel  a j ste  f r a e, sex, race, education and clinic site 
odel  iti ll  justed for body mass index, mean arterial pressure, chol sterol, heart rate, smoking status, physical activity,  
depressive symptoms, prev lent hypert nsion, coronary heart disease, cerebrovacular disease and diabetes mellitus 
 
*Decline ≥ 5 points in global function; ≥ 3 points in verbal memory; ≥ 20 points in psychomotor speed; ≥ 20 points in psychomotor speed;  
≥ 5 po ts in erceptual speed 
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Table 10. Calculated contribution of 1-SD  (389 cm/s) higher baseline PWV to cognitive decline (points per year) 
 
 
Cognitive Measure  
Model 1  
Estimate (95% CI) 
 
Model 2  
Estimate (95% CI) 
Model 3 
Estimate (95% CI) 
 
Global function  
 
 
0.110 (0.017, 0.204)  
 
0.085 ( -0.008, 0.178)  
 
0.081 (-0.012, 0.173)  
 
Verbal memory  
 
 
0.012 (-0.047, 0.070)  
 
0.021 ( -0.038, 0.080)  
 
0.019 (-0.039, 0.078)  
 
Psychomotor  speed  
 
 
0.272 (0.072, 0.471)  
 
0.292 (0.094, 0.491)  
 
0.298 (0.099, 0.498)  
 
Perceptual speed  
 
 
0.018 (-0.040, 0.075)  
 
0.022  ( -0.036, 0.080)  
 
0.019 (-0.039, 0.077)  
 
Model 1 adjusted for clinic site  
Model 2 additionally adjusted for age, sex, race, education, and interaction of each covariate with time 
Model 3 additionally adjusted for body mass index, mean arterial pressure, cholesterol, heart rate, smoking status, physical activity,  
depressive symptoms, prevalent hypertension, coronary heart disease, cerebrovacular disease, diabetes mellitus, and interaction of each 
covariate with time 
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4.1 ABSTRACT  
Central arterial stiffness is increasingly recognized as an important predictor of cardiovascular 
events and mortality in older adults; however, few studies have evaluated the association of 
arterial stiffness with mobility decline, a common consequence of vascular disease.  We 
analyzed the association of pulse wave velocity (PWV), a measure of aortic stiffness, with 
longitudinal gait speed over seven years in 2,172 participants in the Health, Aging and Body 
Composition (Health ABC) Study (mean age ± SD 73.6 ± 2.9 years, 48% men, 39% black).  In 
mixed-effects models adjusted for demographics, each SD higher PWV was associated with 
0.014 (SE 0.004) m/s slower gait at baseline and throughout the study period in the full cohort 
(p<0.001).  This relationship was explained by hypertension and other vascular risk factors.  
However, in participants with peripheral arterial disease (PAD) (n = 261; 12.7%), each SD 
higher PWV was independently associated with a 0.030 (SE 0.010) m/s slower gait speed at 
baseline and throughout the study period (p<0.01).  These findings suggest that aortic stiffness 
may be especially detrimental to mobility in older adults with already compromised arterial 
function. 
4.2 INTRODUCTION 
The primary determinant of systolic hypertension in older adults, central arterial stiffness 
predicts cardiovascular events and mortality independent of systolic blood pressure and other 
vascular risk factors (Sutton-Tyrrell et al., 2005).  Clinical consequences of arterial stiffness have 
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been attributed to early wave reflection from the periphery and loss of cushioning capacity of the 
aorta (O'Rourke, 2007); these risky processes of arterial aging increase cardiac afterload, reduce 
diastolic filling and promote small-vessel injury of the brain and kidney (Mottram et al., 2005; 
O'Rourke, 2007; O'Rourke & Safar, 2005; Safar & Lacolley, 2007).  Aortic stiffness may further 
contribute to resistance vessel hypertrophy and increased vascular resistance (Intengan & 
Schiffrin, 2000; Park & Schiffrin, 2001), impeding blood flow to the peripheral microvasculature 
(Mitchell et al., 2005).  However, the relationship of aortic stiffness with mobility decline, a 
common consequence of vascular disease, has not been well-characterized in older adults. 
Among patients with obstructive peripheral arterial disease (PAD), reductions in aortic 
stiffness by an angiotensin-converting enzyme (ACE) inhibitor were recently found associated 
with improved walking endurance beyond the extent expected by blood pressure lowering 
(Ahimastos et al., 2008), suggesting that aortic stiffness may contribute to compromised leg 
perfusion or diastolic function in PAD.  To evaluate whether aortic stiffness may also in part 
explain mobility decline in initially well-functioning older adults, we analyzed the association of 
PWV with longitudinal gait speed in the Health, Aging, and Body Composition Study and 
evaluated its role in participants with PAD.  Independent associations of PWV with gait speed in 
this cohort may reflect physical functional consequences of impaired diastolic function or 
microvascular perfusion in the presence of aortic stiffness (Ahimastos et al., 2008).   
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4.3 METHODS 
4.3.1 The Health ABC Study and Participants 
From 1997 to 1998 the Health ABC study enrolled 3,075 Medicare-eligible nondisabled men and 
women aged 70-79 from Pittsburgh, Pa. and Memphis, Tn., USA.  The population was 52% 
women and 42% black with a mean age of 73.6 years.  Participants were recruited from 
Medicare-eligible adults with contact information provided by the Centers for Medicare & 
Medicaid Services (formerly the Health Care Financing Administration) on a random sample of 
white and all black beneficiaries in pre-designed zip code areas surrounding the study centers.  
Other household members aged 70-79 were also eligible for recruitment.  Exclusion criteria 
included reported difficulty walking one quarter of a mile, climbing 10 steps without resting, or 
performing basic activities of daily living or need for a walking aid.  The Institutional Review 
Boards of the University of Pittsburgh, Pa. as well as the University of Tennessee at Memphis 
approved the study and written, informed consent was obtained from each volunteer.  PWV data 
were missing for 354 participants due to an equipment problem and an additional 233 
participants who had unusable waveforms.  Of the remaining 2,488 participants, 2,172 had valid 
gait speed data at baseline and were included in the analysis (mean age ± SD 73.6 ± 2.9 years, 
48% men, 39% black).   
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4.3.2 Pulse wave velocity 
Aortic PWV was measured noninvasively via simultaneous Doppler-recorded carotid and 
femoral pulse waveforms (model 810A, 9.0- to 10-MHz probes, Parks Medical Electronics, Inc).  
A minimum of ten beats were recorded for each simultaneous recording site.  Three separate runs 
were recorded for each participant, and all usable runs were averaged to calculate the final PWV 
measure.  The distance between the carotid and femoral recording sites was measured above the 
surface of the body with a tape measure.  The time delay between the feet of the pressure waves 
at each site was divided by the associated distance to calculate PWV in cm/s.  Replicate 
measures of PWV in 14 subjects revealed intraclass correlations of 0.88 between sonographers 
and 0.84 between readers (Sutton-Tyrrell et al., 2005). 
4.3.3 Peripheral arterial disease 
Ankle-arm index (AAI) was calculated as the ratio of the systolic blood pressure obtained in the 
ankle to the systolic blood pressure of the right arm.  Measures were performed twice and the 
results averaged; the lower average value between the two legs was used to define an 
individual’s AAI.  Peripheral arterial disease (PAD) was defined as an AAI less than 0.9, 
according to traditional diagnostic criteria (Yao et al., 1969). 
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4.3.4 Gait speed 
Usual gait speed was assessed over a 20-meter straight course at baseline and annually through 
Year 8, except Year 7.  Participants were instructed to walk at their usual pace from the starting 
point to the end of the course.  Timing began at the first footfall over the starting line and ended 
with the first footfall over the finishing line.   
4.3.5 Covariates 
We considered as potential confounders variables that were identified in the literature as 
confounders of the relationship between vascular disease and physical function, or were 
associated with arterial stiffness and gait speed in this cohort at a significance level of 0.15.  
Selected covariates included smoking status, body-mass index (BMI), physical activity, resting 
heart rate, systolic blood pressure, total cholesterol, prevalent coronary heart disease, diabetes 
and hypertension.  Presence of chronic conditions was determined from participant reports from 
the baseline visit and confirmed by use of specific medications or procedures (Madero et al., 
2009a).  BMI was calculated as measured weight in kilograms divided by measured height in 
meters squared.  Physical activity was assessed by questionnaire and used to calculate the 
kilocalories expended for all forms of walking and exercise, stair climbing and vigorous activity 
in the previous week; participants with at least 1,000 kcal expended were defined as active.  
Systolic blood pressure was measured twice and the results averaged.  Total cholesterol was 
determined from fasting blood samples collected at the baseline clinic visit.   
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Because aortic stiffness is associated with both overt and subclinical cerebrovascular 
disease (Henskens et al., 2008; Sutton-Tyrrell et al., 2005), we also evaluated whether an 
association of PWV with gait speed may be explained by prevalent cerebrovascular disease or 
performance on the Digit Symbol Substitution Test (DSST), a test of attention and psychomotor 
speed (Wechsler Adult Intelligence Scale F Revised, 1981) that is sensitive to cerebral small-
vessel disease (O'Sullivan, Morris, & Markus, 2005) and predicts incident stroke in older adults 
(Elkins, Knopman, Yaffe, & Johnston, 2005). 
4.3.6 Statistical Analysis 
Differences in baseline characteristics across quartiles of PWV and gait speed were evaluated 
using Chi-square tests for categorical variables and Kruskal-Wallis tests or analysis of variance 
for continuous variables.  Mixed-effects models were used to evaluate the association of PWV 
with longitudinal gait speed over seven years.  In these models, coefficients for fixed effect 
variables represent the association of the variable with gait speed (m/s) at baseline and 
throughout the study period; interactions of fixed effect variables with time represent the 
contribution of the variable to the rate of gait speed decline (m/s) per year.  Simple models 
included a random intercept for subject, a random slope with time, clinic site and PWV as fixed 
effects, and the interaction of PWV with time.  A second model additionally adjusted for 
demographics (age, sex, and race) and the interaction of each covariate with time.  A backward 
procedure (p-out = 0.05) was used to build a full model additionally adjusted for vascular risk 
factors and chronic conditions, the interaction of each covariate with time and the interaction of 
PWV with PAD.  Analyses were then repeated in subgroups stratified by PAD and additionally 
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adjusted for prevalent cerebrovascular disease, DSST score, and AAI.  Finally, to evaluate the 
sensitivity of estimates to missing data, we repeated the analysis of the full sample after limiting 
followup to four years.   No structure was imposed on the covariance matrix of the random 
effects.  Continuous covariates were centered to simplify interpretation of model coefficients and 
to reduce multicollinearity.  Analyses were performed in Stata 10 (STATA, Houston, TX). 
4.4 RESULTS 
Mean age (SD) of the cohort was 73.6 (2.9) years; 48% were men and 39% were black (Table 
11).  Participants in higher PWV quartiles were older, more likely to be male, black, less active, 
and have higher BMI, systolic blood pressure, resting heart rate, a history of smoking, and 
prevalent diabetes and hypertension (Table 11).  Higher PWV quartiles were also associated with 
PAD, lower DSST score and slower baseline gait speed (Table 12).   
In mixed models adjusted for demographics, each SD higher PWV was associated with a 
0.014 m/s slower gait speed at baseline and throughout the study period, represented by the 
significant main effect of PWV (p<0.01) (Table 13).  The effect was attenuated after additional 
adjustment for vascular risk factors and chronic conditions (Model 3); the covariates BMI, 
systolic blood pressure, heart rate, diabetes and hypertension were particularly important to 
explain the association of PWV with gait speed.  No significant interaction was identified for 
PWV with time, indicating no significant contribution of PWV to the longitudinal decrease in 
gait speed.   
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Although the interaction of PWV with PAD was not statistically significant, in analyses 
restricted to participants with PAD (n = 261; 12.7%), each SD higher PWV was associated with 
a 0.030 (SE 0.010) m/s slower gait speed at baseline and through the study period after 
adjustment for demographics, risk factors and chronic conditions (p<0.01) (Table 14).  This 
effect did not substantially change after additional adjustment for prevalent cerebrovascular 
disease, DSST score, or AAI.  As in the full cohort, the interaction of PWV with time was 
nonsignificant. 
In the full cohort, significant interactions with time were identified for the covariates age, 
sex, race, hypertension and cerebrovascular disease in a full model of gait speed decline.  
Calculated contributions to annual gait speed decline, represented by interaction terms for each 
covariate with time, were modest although statistically significant: -0.0008 m/s per year older 
age at baseline; -0.006 m/s each for male sex and white race; -0.003 m/s for prevalent 
hypertension; and -0.007 m/s for cerebrovascular disease (p<0.01 for all).   
Finally, 1673 (77%) of participants completed gait speed testing at Year 5 and 1219 
(56%) at Year 8.  In analyses restricted to followup through Year 5, estimates for PWV and the 
interaction of PWV with time did not substantially change, suggesting reported estimates are not 
sensitive to missing observations.    
4.5 DISCUSSION 
Although PWV was not independently associated with gait speed in this initially well-
functioning cohort, among those with evidence of PAD, higher PWV was associated with slower 
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gait independent of hypertension and other vascular risk factors.  These data suggest that aortic 
stiffness may be especially detrimental to mobility in older adults with already compromised 
arterial function.  
Cardiovascular consequences of arterial stiffening may be explained by gradual loss of 
the cushioning capacity of the aorta and early wave reflection from the periphery, resulting in 
small-vessel injury of target organs and reduced diastolic filling (O'Rourke, 2007; O'Rourke & 
Safar, 2005; Safar & Lacolley, 2007).  Current findings are consistent with those of a recent 
publication that found arterial stiffness independently associated with impaired functional 
capacity in patients evaluated for peripheral arterial disease (PAD) (Ahimastos et al., 2008), and 
further suggest a clinically important synergistic relationship of aortic stiffness and PAD.  In a 
recent randomized trial among PAD patients, reduction of PWV by an ACE inhibitor was 
associated with improved performance on a treadmill walk test, consistent with the hypothesis 
that arterial stiffness may in part mediate the relationship of PAD with functional impairment by 
contributing to resistance vessel hypertrophy and increased vascular resistance. These data 
suggest a potential to improve peripheral perfusion and walking distance through the reduction 
of arterial stiffness in individuals with PAD (Ahimastos et al., 2008).  
Although we did not identify an association of PWV with rate of gait speed decline, this 
analysis may be limited by the initially high mobility status of the sample, in which no 
participants reported difficulty walking and only 7% had gait speed below 1.0 m/s, a clinically 
relevant cutpoint found predictive of lower extremity limitation and hospitalization (Cesari et al., 
2005).  It is also possible that arterial stiffness may have contributed to gait decline prior to our 
observation, resulting in the slower gait observed throughout the study period in participants with 
PAD who also had elevated PWV.  These data are consistent with an influence of the oscillatory 
 70 
 
component of blood pressure, or pulse pressure, on the structure and function of the peripheral 
vasculature in PAD (Amoh-Tonto et al., 2009).  With widening of the pulse pressure, primarily 
determined by altered wave reflections with aortic stiffness, lower diastolic pressure may be 
inadequate to overcome increased peripheral vascular resistance associated with both obstructive 
atherosclerosis and arterial stiffness (Amoh-Tonto et al., 2009).  Resulting insufficient leg 
perfusion during muscle contraction may account for slower walking speed even in the absence 
of intermittent claudication.  Because the association of aortic stiffness with slower gait in PAD 
was not explained by AAI, these data may suggest a value for PWV in identifying individuals 
with PAD who are at highest risk of functional decline. 
The independent association of hypertension with accelerated gait decline in the full 
cohort is consistent with previous data (Hajjar, Lackland, Cupples, & Lipsitz, 2007) including a 
contribution of cerebral microvascular disease to functional decline in aging (Rosano, Kuller et 
al., 2005; Silbert, Nelson, Howieson, Moore, & Kaye, 2008; Starr et al., 2003).  Considered 
evidence of cerebral small vessel injury (Black et al., 2009), hyperintensities of white matter 
tracts on brain MRI are closely associated with elevated systolic blood pressure (Longstreth et 
al., 1996) and predict gait speed decline and incident physical impairment in older adults 
(Rosano, Kuller et al., 2005).  The relationship of hypertension with functional decline may be 
further mediated by chronic inflammation (Brinkley et al., 2009; Cesari et al., 2004; Kritchevsky, 
Cesari, & Pahor, 2005), oxidative stress (Semba et al., 2007), alterations in the renin-angiotensin 
aldosterone system (Carter, Onder, Kritchevsky, & Pahor, 2005), or deficits in executive 
cognitive function (Royall, Palmer, Chiodo, & Polk, 2004).  Our findings do not suggest that the 
contribution of hypertension to gait speed decline is explained by underlying arterial stiffness.   
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Strengths of this study include the large, community-based population, ability to account 
for several potential confounders, and repeated assessment of gait speed, a reliable, valid 
measure of physical function that predicts incident disability in older adults (Guralnik et al., 
2000).  The analysis may be limited by nonrandom withdrawal of participants with chronic 
conditions, in that participants experiencing the greatest declines in gait speed may have been 
unable to continue study participation.  However, analyses restricted to four years of followup 
did not suggest that estimated associations are sensitive to missing observations.   Finally, gait 
speed and other lower-extremity performance measures may not capture subtle functional 
changes in healthier older adults; rather, extended walking tests (Newman et al., 2006; 
Simonsick et al., 2001) may be more sensitive to diastolic dysfunction associated with aortic 
stiffness.   
In summary, arterial stiffness was inversely related to gait speed in participants 
with PAD, but was not independently associated with gait speed or the rate of gait speed decline 
in the full cohort.  The association of hypertension with accelerated gait speed decline in this 
cohort reinforces the value of blood pressure control in maintaining function in aging.  Current 
evidence implicates arterial stiffness as a potential target of interventions to improve peripheral 
perfusion and walking performance in PAD.  More work is needed to evaluate whether reduction 
of aortic stiffness may reduce risk of functional decline and disability in PAD independent of 
blood pressure lowering.     
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Mean ± SD or %  
 Total  
( 312-2998) 
 
n=2172 
Q1 
(312-636) 
 
n=543 
Q2 
(636-800) 
 
n=545 
Q3 
(801-1046) 
 
n=541 
Q4 
(1047-2998) 
 
n=543 
 
p-value 
Age, years  
 
73.6 ± 2.9  73.3 ± 2.8  73.5 ± 2.8  73.9 ± 2.9  73.9 ± 2.8  <0.01 
Men  
 
48.1 44.9 44.2 50.1 53.2 <0.01 
Black  
 
38.5 33.5 37.3 39.9 43.5 <0.01 
BMI, kg/m 2 
 
27.3 ± 4.7  26.1 ± 4.4  27.4 ± 4.5  28.1 ± 4.8  27.4 ± 4.8  <0.01 
Systolic blood 
pressure, mmHg  
135.5 ± 19.3 129.8 ± 19.3  133.9 ± 18.6  137.5 ± 19.0 140.6 ± 19.5  <0.01 
Heart rate, bpm  64.5 ± 10.6  62.0 ± 9.9  64.4 ± 9 .9  65.4 ± 10.5  66.4 ± 11.5  <0.01 
Cholesterol, 
mg/dL  
203.7 ± 37.8 203 ± 35.0  204.7 ± 36.3  204.5 ± 40.8 202.7 ± 38.9  0.74 
Current or former 
smoker  
55.4 49.5 54.1 59.7 58.2 <0.01 
Physical activity 
> 1000 kcal/wk  
32.9 37.6 33.0 31.1 29.8 0.04 
Coronary hear t 
disease  
18.4 15.9 17.2 21.3 19.3 0.11 
Diabetes  14.0 8.3  12.0 17.0 19.6 <0.01 
Hypertension  
 
49.0 36.9 46.6 52.2 60.5 <0.01 
 
Table 11. Baseline characteristics of the cohort by quartiles (range in parentheses) of PWV (cm/s) 
  
Table 12. Baseline characteristics of the cohort by quartiles (range in parentheses) of PWV (cm/s) 
Mean ± SD or % 
 
 Total  
( 312-2998) 
 
n=2172 
Q1 
(312-636) 
 
n=543 
Q2 
(636-800) 
 
n=545 
Q3 
(801-1046) 
 
n=541 
Q4 
(1047-2998) 
 
n=543 
 
p-value 
Gait speed, m/s 1.34 ± 0.25 1.38 ± 0.25 1.35 ± 0.25 1.31 ± 0.26 1.32 ± 0.24 <0.01 
DSST score 36.5 ± 14.5 39.2 ± 15.1 37.6 ± 14.1 34.7 ± 14.3 34.7 ± 13.8 <0.01 
Cerebrovascular 
disease, % 
7.4 6.9 6.3 6.9 9.3 0.25 
AAI < 0.9, % 12.7 8.1 10.3 14.3 18.2 <0.01 
DSST = Digit Symbol Substitution Test 
 
 
Table 13. Coefficients and standard errors (value in parenthese s) estimated by mixed models of PWV as a 
predictor of longitudinal gait speed (m/s) in the full cohort (n = 2172) 
 
 Model 1 Model 2 Model 3 
PWV (SD)  -0.019 (0.004)* -0.014 (0.004)* -0.005 (0.004) 
Time (yrs) -0.041 (0.001)** -0.039 (0.001)** -0.038 (0.001)* 
PWV*Time -0.001 (0.001) -0.001 (0.001) 0.000 (0.001) 
* p<0.05, **p<0.01 
 
Model 1 adjusted for site 
Model 2 additionally adjusted for age, sex, race, and interaction of each covariate with time 
Model 3 additionally adjusted for BMI, systolic blood pressure, heart rate, total cholesterol, smoking, 
physical activity, coronary heart disease, diabetes, hypertension, and interaction of each covariate with 
time 
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Table 14. Coefficients and standard errors (values in parentheses) estimated by mixed models of PWV as a 
predictor of longitudinal gait speed (m/s) in participants with PAD (AAI < 0.9; n = 261) 
* p<0.05, **p<0.01 
 Model 1 Model 2 Model 3 
PWV (SD) -0.033 (0.011)** -0.032 (0.010)** -0.030 (0.010)** 
Time (yrs) -0.044 (0.002)** -0.046 (0.004)** -0.046 (0.004)** 
PWV*Time 0.001 (0.002) 0.001 (0.002) 0.001 (0.002) 
 
Model 1 adjusted for site 
Model 2 additionally adjusted for age, sex, race, and interaction of each covariate with time 
Model 3 additionally adjusted for BMI, systolic blood pressure, heart rate, total cholesterol, smoking, 
physical activity, coronary heart disease, diabetes, hypertension, and interaction of each covariate with 
time 
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5.1 ABSTRACT 
Background/Aims:  Both cognitive and physical performance declines are important prognostic 
factors for mortality in community-dwelling older adults.  Few studies have evaluated whether 
rates of decline in each domain predict mortality independent of each other or baseline 
performance.  Methods: Global cognitive function (Modified Mini-Mental State Examination 
[3MS]) and usual gait speed (m/s) over 20 meters were assessed at baseline (1997/98) and after 
four years (2001/02) in the Health, Aging, and Body Composition (Health ABC) Study.  Total 
and cardiovascular mortality were ascertained following the 2001/02 visit in 2,345 participants 
who had valid 3MS or gait speed data from 1997/98 and 2001/02  (mean age ± SD 73.5 ± 2.8 
yrs; 47% men; 38% black).  Results: 521 deaths, including 189 (36.3%) cardiovascular deaths, 
occurred by the end of follow-up (median of 5.4 years).  In a multivariate Cox proportional 
hazards model predicting total mortality, greater rates of decline in 3MS score and gait speed 
over four years were independently associated with greater risk: HR (95%CI) 1.18 (1.04, 1.35) 
per SD decrease in 3MS score; 1.59 (1.39, 1.81) per SD decrease in gait speed after adjustment 
for baseline 3MS score and gait speed, demographic and health characteristics.  Concurrent 3MS 
and gait speed declines were more specifically related to cardiovascular mortality: HR (95%CI) 
4.46 (2.36, 8.41) relative to no decline in either test.  Conclusion: In this initially well-
functioning cohort, rates of decline in 3MS score and gait speed, independent of each other, 
baseline performance and traditional risk factors, were associated with greater risk of total and 
cardiovascular mortality.  These data suggest a prognostic value for followup assessments of 
both cognitive and physical performance in community-dwelling older adults.  
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5.2 INTRODUCTION 
Both cognitive and physical performance measures provide valuable prognostic information in 
older adults living in the community (Guralnik et al., 2000; Spiers et al., 2005).  In the 
Cardiovascular Health Study, the combination of lower scores on the Digit Symbol Substitution 
Test (DSST) and slower gait was found to improve prediction of disability and mortality, beyond 
either of these tests alone (Rosano et al., 2008).  Co-occurrence of poor cognitive and physical 
performance in this cohort may reflect a shared cerebrovascular pathogenesis or general 
physiological deterioration associated with increased disability and mortality risk. 
Although clinical risks associated with either cognitive or physical declines are well-
described (Perera, Studenski, Chandler, & Guralnik, 2005; Schupf et al., 2005; van Gelder, 
Tijhuis, Kalmijn, Giampaoli, & Kromhout, 2007), few studies have evaluated risks associated 
with changes in cognitive and physical function in combination or in relation to previous 
performance.  Importantly, independent risks associated with rates of decline in each domain 
would suggest a prognostic value for followup measures of both cognitive and physical 
performance.  Moreover, if mortality risks associated with rates of functional decline is found 
attenuated in individuals with high baseline performance, these data may stress the importance of 
baseline performance as an indication of functional reserve (Newman et al., 2009; Stern, 2009).   
To clarify the predictive value of changes in both cognitive and physical performance 
in aging, we compared the associations of rates of decline in Modified Mini-Mental State 
Examination (3MS) score and gait speed with all-cause and cardiovascular mortality risk in the 
Health, Aging, and Body Composition (Health ABC) Study.  We then evaluated whether 
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mortality risks associated with accelerated cognitive and physical declines are attenuated among 
participants who were initially high-functioning.   
5.3 METHODS 
5.3.1 The Health ABC Study and Participants 
From 1997 to 1998 the Health ABC Study enrolled 3,075 Medicare-eligible nondisabled men 
and women aged 70-79 from Pittsburgh, Pa. and Memphis, Tenn., USA.  The population was 
52% women and 58% white with a mean age of 73.6 years.  Participants were recruited from 
Medicare-eligible adults with contact information provided by the Centers for Medicare & 
Medicaid Services (formerly the Health Care Financing Administration) on a random sample of 
white and all black beneficiaries in pre-designed zip code areas surrounding the study centers.  
Other household members aged 70-79 were also eligible for recruitment.  Exclusion criteria were 
difficulty in either walking without an assistive device, walking one quarter of a mile or climbing 
10 steps without resting.  Participants were contacted every six months, alternating in-person 
examinations and telephone interviews.  Both Institutional Review Boards of the University of 
Pittsburgh, Pa. as well as the University of Tennessee at Memphis approved the study and 
written, informed consent was obtained from each volunteer.  Of the 3,075 participants enrolled 
in Health ABC, 2,345 had valid 3MS or gait speed data from the 1997/98 and 2001/02 visits and 
were included in the current analysis (mean age ± SD 73.5 ± 2.8 yrs; 47% men; 38% black). 
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5.3.2 Functional measures 
Cognitive and physical function were assessed at the 1997/98 and 2001/02 visits using the 
Modified Modified Mini-Mental Status Exam (3MS) (Teng & Chui, 1987) and usual gait speed.  
The 3MS is a commonly used evaluation of global cognitive function, including orientation, 
attention, calculation, language and short-term memory.  Scores can range from 0 to 100 points, 
with lower scores indicating poorer performance.  Gait speed, a reliable and valid measure of 
physical function (Guralnik et al., 2000), was measured as the time needed to walk a 20-meter 
straight course at usual pace.  Timing began at the first footfall over the starting line and ended 
with the first footfall over the finishing line. 
5.3.3 Mortality Outcomes 
Total mortality outcomes were ascertained from the 2001/2002 visit through November 27 2007.  
Cardiovascular mortality outcomes were ascertained from the 2001/2002 visit through December 
31 2006 (Memphis) or June 30 2007 (Pittsburgh), when adjudication was complete for each site.  
A central committee adjudicated immediate and underlying causes of death by review of hospital 
records, death certificates, informant interviews and autopsy data.  Cardiovascular mortality was 
defined as atherosclerotic cardiovascular disease (definite fatal myocardial infarction, or definite 
or possible fatal coronary heart disease), stroke, atherosclerotic disease other than coronary or 
cerebrovascular, and other cardiovascular disease. 
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5.3.4 Covariates 
Health characteristics that are associated with mortality and were considered potential 
confounders included smoking status, body-mass index (BMI), physical activity, depressive 
symptoms, prevalent coronary heart disease, diabetes, hypertension and peripheral arterial 
disease as ascertained from the 1999/00 or 2001/02 clinic visit.  Presence of chronic conditions 
was determined from participant reports and confirmed by use of specific mediations or 
procedures (Madero et al., 2009a).  BMI was calculated as measured weight in kilograms divided 
by measured height in meters squared.  Walking frequency and duration was determined from 
responses to question which distinguished walking for exercise and other types of walking from 
a standardized, interviewer-administered physical activity battery (Brach et al., 2004).  
Participants walking a total of <30 minutes per week were defined as sedentary. Depressive 
symptoms were assessed using the Centers for Epidemiologic Studies of Depression 10-item 
scale (CESD-10) (Andresen et al., 1994).  Ankle-arm index was calculated as the ratio of the 
systolic blood pressure obtained in the ankle to the systolic blood pressure of the right arm.  
Measures were performed twice and the results were averaged; the lower average value between 
the two legs was used to define an individual’s ankle-arm index.  Peripheral arterial disease was 
defined as ankle-arm index less than or equal to 0.9, according to traditional diagnostic criteria 
(Yao et al., 1969).   
To evaluate whether subclinical or undiagnosed conditions may in part explain 
associations of rates of performance decline with mortality, we further considered as covariates 
systolic blood pressure, total cholesterol and fasting glucose evaluated at the 1999/00 or 2000/01 
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visit.  Systolic blood pressure was measured twice and the results averaged.  Cholesterol and 
glucose levels were measured after an overnight fast. 
 
5.3.5 Statistical analysis 
Chi-square tests and unpaired t-tests were used to test differences in characteristics by survival 
status.  Kaplan-Meier plots and log-rank tests were used to compare survival curves across 
categories of decline in 3MS and gait speed from 1997/98 – 2001/02, where 3MS decline was 
defined as change of 5 points or more and gait speed decline as 0.4 m/s (average change of 0.1 
m/s per year) or more, according to traditional criteria (Andrew & Rockwood, 2008; Perera et 
al., 2005).  Crude incidence rates were calculated per 1,000 person years.  Cox proportional 
hazards models were used to estimate hazard ratios (HRs) for changes in each test as predictors 
of total and cardiovascular mortality.  The proportional hazards assumption was verified for all 
independent variables using log-log plots and Grambsch and Therneau tests.  Simple models of 
3MS change or gait speed change as predictors of mortality adjusted for baseline 3MS score or 
gait speed, age, sex, race, education and clinic site.  A second model included both change 
measures in a single model.  Full models additionally adjusted for potential confounders (BMI, 
physical activity, depressive symptoms, smoking, coronary heart disease, cerebrovascular 
disease, hypertension, diabetes, peripheral arterial disease) and indicators of subclinical or 
undiagnosed conditions (systolic blood pressure, total cholesterol and fasting glucose). Analyses 
were repeated for non-cardiovascuar deaths to determine whether cardiovascular deaths may 
account for associations of rates of functional decline with total mortality. 
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To evaluate whether mortality risks associated with rates of performance decline were 
attenuated in participants who were initially high-functioning, we tested interactions of 3MS 
score and gait speed change with baseline performance in each measure and stratified analyses at 
the median baseline performance (93 for 3MS; 1.34 m/s for gait speed).  To determine whether 
accelerated declines in each measure may synergistically increase mortality risk, we then tested 
the interaction of 3MS score change with gait speed change and analyzed mortality risks 
associated with concurrent declines in 3MS and gait speed as defined in Kaplan-Meier plots.  
Receiver operator characteristic (ROC) curves (Cook, 2008) were used to compare predictive 
values of alternative cutpoints for declines in 3MS score (≥4 or ≥6 point change) and gait speed 
(≥0.3 or ≥ 0.5 m/s change).   
      Finally, we adjusted each full model for performance at followup (2001/02) rather than 
baseline (1997/98) to determine whether effects of changes in 3MS and gait speed may be 
explained by the most recent performance (DeFries, Avendano, & Glymour, 2009).  Analyses 
were performed in Stata 10 (STATA, Houston, TX). 
5.4 RESULTS 
Mean age ± SD of the 2,345 participants was 73.5 ± 2.8 years; 47% were men and 38% black. 
521 deaths (45.4/1,000 p-y), including 189 cardiovascular deaths (17.5/1,000 p-y), occurred by 
the end of follow-up (median of 5.4 years) from the 2001/02 visit. Survivors had higher 3MS 
scores (91.5 ± 7.1 vs 89.0 ± 9.0 points) and faster gait speed (1.37 ± 0.25 vs 1.30 ± 0.25 m/s) at 
baseline, and declined less in each test after four years: -0.27 ± 5.8 vs -2.31 ± 8.5 points for 3MS 
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change; -0.24 ± 0.20 vs -0.29 ± 0.21 m/s for gait speed change (p<0.001 for all) (Table 15).  
Figures 1 and 2 show survival curves for each outcome by categories of decline in 3MS score 
and gait speed.  Total and cardiovascular mortality rates were highest for participants with 
evidence of both cognitive and physical declines, and lowest for those with no evidence of 
decline in either domain.  
In separate Cox proportional hazards models of change in each test as predictors of 
total mortality, greater rates of decline in 3MS score and gait speed were associated with higher 
risk after adjustment for baseline performance and demographics: HR (95%CI) 1.28 (1.19, 1.38) 
per SD decrease in 3MS score; 1.56 (1.39, 1.75) per 0.1 m/s decrease in gait speed.  Inclusion of 
both change measures in a single model only slightly attenuated hazard ratios for decline in each 
test (Table 16).  HRs were moderately strengthened or attenuated after further adjustment for risk 
factors and chronic conditions but changed minimally after additional adjustment for indicators 
of subclinical or undiagnosed disease.   
In a fully adjusted model of cardiovascular mortality, changes in 3MS score and gait 
speed change remained independently associated with mortality risk and HRs for 3MS score 
change were substantially strengthened (Table 17).  In a final model of non-cardiovascular 
mortality, only gait speed change remained associated with mortality risk: HR (95%CI) 1.02 
(0.86, 1.21) for 3MS score change: 1.66 (1.41, 1.97) for gait speed change.  After adjustment for 
performance at followup (2001/02) rather than baseline (1997/98), mortality risks associated 
with changes in 3MS score and gait speed were no longer significant.  
Mortality risk associated with 3MS decline (5 points or more) was higher among the 
subgroup of participants with higher baseline 3MS score: fully adjusted HR (95% CI) 1.71 (1.21, 
2.42) vs. 1.28 (0.92, 1.78) for participants with scores above vs. below the median of 93.  By 
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contrast, risk associated with gait speed decline (0.4 m/s or more) was higher among participants 
with slower baseline gait speed: fully adjusted HR (95% CI) 1.60 (1.16, 2.20) vs. 2.02 (1.30, 
3.12) for participants with gait speed above vs. below the median of 1.34 m/s.  However, 
interactions of change in each test with baseline performance were nonsignificant, preventing a 
stronger conclusion that mortality risks associated with functional declines may vary by baseline 
functional status. 
Although the interaction of 3MS score change with gait speed change was 
nonsignificant, concurrent declines in 3MS score and gait speed were associated with higher 
mortality risks relative to decline in neither or one test, independent of baseline performance, 
demographic and health characteristics (Tables 18-19). HRs for concurrent declines remained 
significant after adjustment for 3MS score and gait speed at followup (2001/02) rather than 
baseline (1997/98).  
Finally, ROC curves showed similar predictive values for alternative cutpoints for 
3MS and gait speed declines, while HRs gradually increased with worsening decline in each test.  
These data do not suggest a threshold effect of performance declines in risk prediction.  
5.5 DISCUSSION 
In this cohort of initially well-functioning older adults, rates of decline in 3MS score and gait 
speed over four years predicted subsequent mortality independent of each other, demographic 
and health characteristics.  Co-occurring declines in cognitive and physical function were more 
predictive of mortality relative to declines in either domain alone.  These data suggest that 
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repeated assessments of cognitive and physical performance, alone and in combination, may be 
important prognostic factors in older adults living in the community.   
Cognitive and physical performance measures are widely recognized as valuable 
predictors of adverse outcomes in well-functioning older adults.  In several cohorts, poorer 
scores on the 3MS or abbreviated version, the Mini-Mental State Examination (MMSE) 
(Folstein, Folstein, & McHugh, 1975), were found associated with greater risk of incident stroke 
(DeFries et al., 2009), disability (Lee, Kim, Lee, Han, & Kim, 2005), and mortality (Lavery, 
Dodge, Snitz, & Ganguli, 2009) in the absence of dementia.  In nondisabled populations, slower 
gait at usual pace predicted incident disability (Guralnik et al., 2000), hospitalization (Cesari et 
al., 2005), and mortality (Abellan van Kan et al., 2009; Cesari et al., 2005).  Shared risk factors 
for cognitive and physical impairments include smoking (Atkinson et al., 2005),  hypertension 
and cardiovascular disease (Newman et al., 2009), suggesting an important potential to prevent 
or delay functional decline in late life. 
In the Cardiovascular Health Study (CHS), DSST score and gait speed were recently 
found to improve prediction of disability and mortality beyond either test alone (Rosano et al., 
2008).  Risks associated with rates of cognitive and physical decline in combination and in 
relation to baseline performance have not previously been evaluated.   Our finding that 
accelerated declines in 3MS score and gait speed, independent of each other, baseline 
performance and other risk factors, predicted total and cardiovascular mortality suggest a value 
for both followup assessments in risk stratification.  In fact, concurrent cognitive and physical 
declines more strongly predicted mortality risk relative to declines in neither or only one 
measure, suggesting a combined effect of declines in both domains.  This risky pattern of 
functional decline may indicate an ongoing process of physiological deterioration associated 
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with chronic inflammation or oxidative stress, two proposed determinants of biological aging 
(Simm et al., 2008) and functional decline (Penninx et al., 2004; Semba et al., 2007; Tracy, 
2003).  Alternatively, the more specific association of co-occurring declines with cardiovascular 
mortality in this cohort may reflect a shared cerebrovascuar pathogenesis (Rosano, Aizenstein, 
Studenski, & Newman, 2007) believed to preferentially influence executive and motor functions 
(Pugh & Lipsitz, 2002).  
Our finding that mortality risks associated with rates of cognitive and physical decline 
were independent of baseline performance suggests that these risks are not explained by low 
functional reserve.  In fact, risks associated with accelerated functional declines in this cohort 
were not restricted to participants with lower baseline performance, suggesting a prognostic 
value for followup measures in older adults of various levels of function. Importantly, elevated 
mortality risks associated with concurrent cognitive and physical declines were also independent 
of followup performance, indicating that risk prediction may be improved by knowledge of 
previous performance even when current performance measures are available.  
Our study has several limitations.  In initially high-functioning participants, subtle 
cognitive and physical declines may have been obscured by ceiling effects of the 3MS and gait 
speed tests.  Measures of brain integrity were not available to evaluate the hypothesis that focal 
changes in executive function-related networks may account in part for co-occurring cognitive 
and physical declines.  Also, because participants who experienced the greatest functional 
declines may have been unable to complete the followup visit, our results may not generalize to 
less healthy participants.  Strengths of this study include the large community-dwelling 
population, long followup, ability to account for several important confounders, and availability 
of two reliable and valid performance measures to evaluate longitudinal functional decline.     
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In this cohort of initially well-functioning older adults, rates of cognitive and physical 
performance decline predicted total and cardiovascular mortality, independent of each other, 
baseline performance, and traditional risk factors.  Concurrent cognitive and physical declines 
were associated with greater mortality risk relative to decline in either domain, suggesting a 
value for followup assessments of both cognitive and physical performance in identifying 
individuals at highest risk of adverse outcomes.  Further understanding of the contributions of 
oxidative stress, chronic inflammation, and cerebrovascular alterations to cognitive and physical 
declines in aging may guide preventative strategies to extend the healthy lifespan.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 15. Characteristics (mean ± SD or %) of the population 
  Survived 
N = 1770 
Total mortality 
N = 521 
CVD mortality 
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 N = 189 
 Age, years 77.3 ± 2.8 78.1 ± 2.9*** 78.2 ± 3.0*** 
 
Male  44.8 55.9***  52.4* 
 
Black 35.5 44.7***  47.1** 
 
Education > 12 years  46.7 38.0***  40.6 
 
Baseline 3MS score  91.5 ± 7.1 89.0 ± 9.0*** 89.3 ± 8.2***  
 
3MS score Δ -0.27 ± 5.8 -2.31 ± 8.5*** -3.38 ± 9.2***  
 
Baseline gait speed, m/s 1.37 ± 0.25 1.30 ± 0.25*** 1.29 ± 0.24***  
 
Gait speed Δ, m/s -0.24 ± 0.20 -0.29 ± 0.21*** -0.29 ± 0.19* 
 
 BMI (kg/m2) 27.4 ± 4.8 26.5 ± 5.1 26.5 ± 4.8** 
 
 Sedentary 50.6 55.6* 
 
58.8* 
CES_D10 4.8 ± 4.2 5.6 ± 4.6*** 5.4 ± 4.8**  
 
History of smoking 52.3 62.5***  
 
61.4* 
Coronary heart disease 22.6 30.8***  43.1*** 
 
Cerebrovascular disease 7.4 12.2***  15.5*** 
 
Hypertension 66.3 72.0*  77.3** 
 Diabetes 20.2 26.1*  31.2*** 
 AAI < 0.9 13.1 26.4*** 
 
32.1 
 Systolic blood pressure 
(mmHg) 
135.1 ± 20.2 137.1 ± 24.1 136.4 ± 25.4  
 
 Total cholesterol (mg/dL) 192.7 ± 36.4 187.7 ± 38.5** 187.2 ± 40.1 
 
 Fasting glucose (mg/dL) 100.6 ± 24.8 106.7 ± 37.9*** 103.4 ± 31.6*** 
 
 
Characteristics evaluated in 2000/01 or 2001/02 unless otherwise noted.  
Δ = change from 1997/98 to 2001/02 
*p<0.05, **p<0.01, ***p<0.001 for t-test or chi-square test for comparisons by survival 
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P < 0.001
Figure 1. Kaplan-Meier plot of total mortality by 3MS and gait speed decline* 
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Figure 2. Kaplan-Meier plot of cardiovascular mortality by 3MS and gait speed decline* 
*3MS decline defined as change ≥ 5 points and gait speed decline as change ≥ 0.4 m/s from 1997/98 to 
2001/02 
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Table 16. Associations of change in 3MS and gait speed with total mortality risk 
 
Predictor 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
Model 3 
HR (95% CI) 
3MS change, per SD  
(6.5 pts) decrease 
1.28 (1.19, 1.38) 1.23 (1.12, 1.36) 1.18 (1.04, 1.35) 
Gait speed change, per 
SD (0.20 m/s) decrease 
--- 1.50 (1.34, 1.68) 1.59 (1.39, 1.81) 
 
Model 1: baseline 3MS, 3MS change, age, sex, race, education, clinic site 
Model 2: Model 1 + baseline gait speed and gait speed change 
Model 3: Model 2 + BMI, physical activity, depressive symptoms, smoking, coronary heart disease, cerebrovascular 
disease, hypertension, diabetes and peripheral arterial disease 
 
 
 
Table 17. Associations of change in 3MS and gait speed with cardiovascular mortality risk 
 
Predictor 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
Model 3 
HR (95% CI) 
3MS change, per SD  
(6.5 pts) decrease 
1.38 (1.25, 1.53) 1.34 (1.16, 1.55) 1.49 (1.22, 1.84) 
Gait speed change, per 
SD (0.20 m/s) decrease 
--- 1.51 (1.24, 1.83) 1.47 (1.18, 1.84) 
 
Model 1: baseline 3MS, 3MS change, age, sex, race, education, clinic site 
Model 2: Model 1 + baseline gait speed and gait speed change 
Model 3: Model 2 + BMI, physical activity, depressive symptoms, smoking, coronary heart disease, cerebrovascular 
disease, hypertension, diabetes and peripheral arterial disease 
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Table 18. Associations of 3MS and gait speed decline* with total mortality risk 
 
Decline Category 
Events Events per 1,000 
Person-Years 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
No Decline (N = 1,303) 225 34.1 1.00 1.00 
3MS Decline Only (N = 327) 70 44.0 1.37 (1.04, 1.81) 1.22 (0.89, 1.69) 
Gait Speed Decline Only (N = 287) 72 52.3 1.67 (1.25, 2.24) 1.72 (1.26, 2.36) 
Both Declines (N = 93) 72 93.3 2.51 (1.73, 3.63) 2.77 (1.82, 4.21) 
 
Model 1 adjusted for age, sex, race, education, clinic site, baseline 3MS and baseline gait speed 
Model 2 additionally adjusted for BMI, physical activity, depressive symptoms, smoking, coronary heart disease, cerebrovascular disease, hypertension, diabetes 
and peripheral arterial disease 
 
 
Table 19. Associations of 3MS and gait speed decline* with cardiovascular mortality risk 
 
Decline Category 
Events Events per 1,000 
Person-Years 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
No Decline (N = 1,303) 75 11.4 1.00 1.00 
3MS Decline Only (N = 327) 24 15.1 1.47 (0.93, 2.32) 1.52 (0.92, 2.52) 
Gait Speed Decline Only (N = 287) 28 20.3 1.83 (1.11, 3.01) 1.79 (1.06, 3.03) 
Both Declines (N = 93) 16 38.3 3.64 (2.03, 6.57) 4.46 (2.36, 8.41) 
 
Model 1 adjusted for age, sex, race, education, clinic site, baseline 3MS and baseline gait speed 
Model 2 additionally adjusted for BMI, physical activity, depressive symptoms, smoking, coronary heart disease, cerebrovascular disease, hypertension, diabetes 
and peripheral arterial disease 
 
*3MS decline defined as change ≥ 5 points and gait speed decline as change ≥ 0.4 m/s from 1997/98 to 2001/02 
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6.0  DISCUSSION 
 
6.1 SUMMARY OF FINDINGS 
In this community-dwelling cohort, greater central arterial stiffness, a hallmark of vascular 
aging, was associated with poorer performance in several cognitive domains and predicted 
longitudinal decline in psychomotor speed independent of hypertension and other vascular risk 
factors.  These findings are consistent with a vulnerability of the deep white matter to 
cerebrovascular injury, as stiffened vessels transmit damaging flow pulsations into the fragile 
cerebral microvasculature.   
Also independent of vascular risk factors, elevated arterial stiffness was associated with 
slower gait speed in participants with peripheral arterial disease (PAD), suggesting vascular 
stiffening may be especially detrimental to mobility in older adults with already compromised 
arterial function.  With widening of the pulse pressure, primarily determined by aortic stiffening, 
lower diastolic pressure and increased vascular resistance may contribute to insufficient leg 
perfusion in peripheral arterial disease.  Because the association of PWV with gait speed in PAD 
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was not explained by ankle-arm index or other risk factors, these data suggest a potential value 
for PWV in identifying older adults with PAD who are at highest risk of mobility impairment.   
In the Health ABC Cognitive Vitality Substudy, poorer verbal memory, global and 
executive function were each associated with slower gait cross-sectionally and predicted 
longitudinal gait speed decline.  Hypertension, peripheral arterial disease and other vascular risk 
factors partially explained the relationship of cognitive performance with gait speed in this 
sample.  These findings are consistent with a shared cerebrovascular pathogenesis underlying 
cognitive and mobility declines, but do not suggest that specific cognitive deficits account for 
gait slowing in aging.   
Finally, in the full Health ABC cohort, greater rates of decline in 3MS score and gait 
speed predicted total and cardiovascular mortality independent of each other, baseline 
performance and traditional risk factors.  These data suggest a prognostic value for follow-up 
assessments of both cognitive and physical function in nondisabled older adults.  The particularly 
risky pattern of concurrent declines in cognitive and physical function may reflect a shared 
cerebrovascular pathogenesis or general degradation of physiologic reserve.   
 
6.2 PUBLIC HEALTH SIGNIFICANCE 
Challenged by growing burdens of chronic disease and disability, aging populations must 
recognize hypertension as a crucial target of strategies to extend the healthy lifespan.   Improved 
efforts to combat hypertension may develop from new understanding of both the pathogenesis 
and consequences of central arterial stiffness, a hallmark of vascular aging.   Several recent 
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publications have identified a potential contribution of arterial stiffness to cognitive decline 
independent of hypertension and other vascular risk factors; these findings have been attributed 
to the transmission of damaging central pressures to the fragile cerebral microvasculature.  Other 
studies have demonstrated associations of deficits in executive function and attention with 
accelerated gait speed decline, consistent with a shared, hypothesized cerebrovascular 
pathogenesis underlying cognitive and motor impairments in aging.  These data suggest an 
important potential to prevent or delay disability through the control of modifiable vascular risk 
factors.   
            Taken together, findings from the Health ABC study implicate central arterial stiffness as a 
determinant both cognitive and physical functional declines, two valuable prognostic factors in  
older adults in the community.  Current evidence supports a direct relationship between blood 
pressure levels, cardiovascular and mortality risks; however, rising prevalence and persistently 
low control rates highlight deficiencies in current approaches to combat hypertension.  More 
work is needed to determine whether reduction of central arterial stiffness may reduce risk of 
functional decline beyond the extent expected by blood pressure lowering.  Promising results of 
several observational studies suggest that angiotensin-converting enzyme (ACE) inhibitors may 
improve mobility and reduce risk of cognitive decline beyond hypertension control; these 
findings may reflect important roles of this specific class of agents in directly altering the 
structure of arterial walls, leading to reductions in large arterial stiffness and improvements in 
microvascular perfusion.  Randomized, controlled trials are warranted to confirm this 
hypothesized advantage of ACE inhibitors over other classes of antihypertensive drugs in 
preventing or delaying functional decline, a looming threat to aging populations. 
   
 95 
 
BIBLIOGRAPHY 
 
Abellan van Kan, G., Rolland, Y., Andrieu, S., Bauer, J., Beauchet, O., Bonnefoy, M., et al. 
(2009). Gait Speed at Usual Pace as a Predictor of Adverse Outcomes in Community-
Dwelling Older People An International Academy on Nutrition and Aging (IANA) Task 
Force. J Nutr Health Aging, 13(10), 881-889. 
 
Agata, J., Nagahara, D., Kinoshita, S., Takagawa, Y., Moniwa, N., Yoshida, D., et al. (2004). 
Angiotensin II receptor blocker prevents increased arterial stiffness in patients with 
essential hypertension. Circ J, 68(12), 1194-1198. 
 
Ahimastos, A. A., Dart, A. M., Lawler, A., Blombery, P. A., & Kingwell, B. A. (2008). Reduced 
arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced 
improvements in walking time in peripheral arterial disease patients. J Hypertens, 26(5), 
1037-1042. 
 
Ahimastos, A. A., Natoli, A. K., Lawler, A., Blombery, P. A., & Kingwell, B. A. (2005). 
Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes 
elastogenic remodeling in cell culture. Hypertension, 45(6), 1194-1199. 
 
Amoh-Tonto, C. A., Malik, A. R., Kondragunta, V., Ali, Z., & Kullo, I. J. (2009). Brachial-ankle 
pulse wave velocity is associated with walking distance in patients referred for peripheral 
arterial disease evaluation. Atherosclerosis. 
 
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994). Screening for 
depression in well older adults: evaluation of a short form of the CES-D (Center for 
Epidemiologic Studies Depression Scale). Am J Prev Med, 10(2), 77-84. 
 
Andrew, M. K., & Rockwood, K. (2008). A five-point change in Modified Mini-Mental State 
Examination was clinically meaningful in community-dwelling elderly people. J Clin 
Epidemiol, 61(8), 827-831. 
 
Atkinson, H. H., Cesari, M., Kritchevsky, S. B., Penninx, B. W., Fried, L. P., Guralnik, J. M., et 
al. (2005). Predictors of combined cognitive and physical decline. J Am Geriatr Soc, 
53(7), 1197-1202. 
 96 
 
Atkinson, H. H., Rosano, C., Simonsick, E. M., Williamson, J. D., Davis, C., Ambrosius, W. T., 
et al. (2007). Cognitive function, gait speed decline, and comorbidities: the health, aging 
and body composition study. J Gerontol A Biol Sci Med Sci, 62(8), 844-850. 
 
Bhuiyan, A. R., Srinivasan, S. R., Chen, W., Paul, T. K., & Berenson, G. S. (2006). Correlates of 
vascular structure and function measures in asymptomatic young adults: the Bogalusa 
Heart Study. Atherosclerosis, 189(1), 1-7. 
 
Blacher, J., Safar, M. E., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2003). 
Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int, 
63(5), 1852-1860. 
 
Black, S., Gao, F., & Bilbao, J. (2009). Understanding white matter disease: imaging-
pathological correlations in vascular cognitive impairment. Stroke, 40(3 Suppl), S48-52. 
 
Blahak, C., Baezner, H., Pantoni, L., Poggesi, A., Chabriat, H., Erkinjuntti, T., et al. (2009). 
Deep frontal and periventricular age related white matter changes but not basal ganglia 
and infratentorial hyperintensities are associated with falls: cross sectional results from 
the LADIS study. J Neurol Neurosurg Psychiatry, 80(6), 608-613. 
 
Ble, A., Volpato, S., Zuliani, G., Guralnik, J. M., Bandinelli, S., Lauretani, F., et al. (2005). 
Executive function correlates with walking speed in older persons: the InCHIANTI study. 
J Am Geriatr Soc, 53(3), 410-415. 
 
Boutouyrie, P., Laurent, S., & Briet, M. (2008). Importance of arterial stiffness as cardiovascular 
risk factor for future development of new type of drugs. Fundam Clin Pharmacol, 22(3), 
241-246. 
 
Brach, J. S., Simonsick, E. M., Kritchevsky, S., Yaffe, K., & Newman, A. B. (2004). The 
association between physical function and lifestyle activity and exercise in the health, 
aging and body composition study. J Am Geriatr Soc, 52(4), 502-509. 
 
Brach, J. S., Solomon, C., Naydeck, B. L., Sutton-Tyrrell, K., Enright, P. L., Jenny, N. S., et al. 
(2008). Incident physical disability in people with lower extremity peripheral arterial 
disease: the role of cardiovascular disease. J Am Geriatr Soc, 56(6), 1037-1044. 
 
Breteler, M. M. (2000). Vascular risk factors for Alzheimer's disease: an epidemiologic 
perspective. Neurobiol Aging, 21(2), 153-160. 
 
Brinkley, T. E., Leng, X., Miller, M. E., Kitzman, D. W., Pahor, M., Berry, M. J., et al. (2009). 
Chronic inflammation is associated with low physical function in older adults across 
multiple comorbidities. J Gerontol A Biol Sci Med Sci, 64(4), 455-461. 
 
Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Annu Rev Med, 46, 
223-234. 
 97 
 
Buckner, R. L. (2004). Memory and executive function in aging and AD: multiple factors that 
cause decline and reserve factors that compensate. Neuron, 44(1), 195-208. 
 
Buschke, H., & Fuld, P. A. (1974). Evaluating storage, retention, and retrieval in disordered 
memory and learning. Neurology, 24(11), 1019-1025. 
 
Carter, C. S., Onder, G., Kritchevsky, S. B., & Pahor, M. (2005). Angiotensin-converting 
enzyme inhibition intervention in elderly persons: effects on body composition and 
physical performance. J Gerontol A Biol Sci Med Sci, 60(11), 1437-1446. 
 
Cesari, M., Kritchevsky, S. B., Penninx, B. W., Nicklas, B. J., Simonsick, E. M., Newman, A. 
B., et al. (2005). Prognostic value of usual gait speed in well-functioning older people--
results from the Health, Aging and Body Composition Study. J Am Geriatr Soc, 53(10), 
1675-1680. 
 
Cesari, M., Penninx, B. W., Pahor, M., Lauretani, F., Corsi, A. M., Rhys Williams, G., et al. 
(2004). Inflammatory markers and physical performance in older persons: the 
InCHIANTI study. J Gerontol A Biol Sci Med Sci, 59(3), 242-248. 
 
Cook, N. R. (2008). Statistical evaluation of prognostic versus diagnostic models: beyond the 
ROC curve. Clin Chem, 54(1), 17-23. 
 
Coppin, A. K., Shumway-Cook, A., Saczynski, J. S., Patel, K. V., Ble, A., Ferrucci, L., et al. 
(2006). Association of executive function and performance of dual-task physical tests 
among older adults: analyses from the InChianti study. Age Ageing, 35(6), 619-624. 
 
Dahlof, B. (2007). Prevention of stroke in patients with hypertension. Am J Cardiol, 100(3A), 
17J-24J. 
 
de Groot, J. C., de Leeuw, F. E., Oudkerk, M., van Gijn, J., Hofman, A., Jolles, J., et al. (2000). 
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann 
Neurol, 47(2), 145-151. 
 
de la Torre, J. C. (2002). Alzheimer disease as a vascular disorder: nosological evidence. Stroke, 
33(4), 1152-1162. 
 
DeFries, T., Avendano, M., & Glymour, M. M. (2009). Level and change in cognitive test scores 
predict risk of first stroke. J Am Geriatr Soc, 57(3), 499-505. 
 
Dernellis, J., & Panaretou, M. (2005). Aortic stiffness is an independent predictor of progression 
to hypertension in nonhypertensive subjects. Hypertension, 45(3), 426-431. 
 
Di Bari, M., Pahor, M., Franse, L. V., Shorr, R. I., Wan, J. Y., Ferrucci, L., et al. (2001). 
Dementia and disability outcomes in large hypertension trials: lessons learned from the 
systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol, 153(1), 72-78. 
 98 
 
Elias, M. F., Robbins, M. A., Budge, M. M., Abhayaratna, W. P., Dore, G. A., & Elias, P. K. 
(2009). Arterial pulse wave velocity and cognition with advancing age. Hypertension, 
53(4), 668-673. 
 
Elkins, J. S., Knopman, D. S., Yaffe, K., & Johnston, S. C. (2005). Cognitive function predicts 
first-time stroke and heart disease. Neurology, 64(10), 1750-1755. 
 
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2004). Applied Longitudinal Analysis. 
Hoboken, NJ: John Wiley & Sons, Inc. 
 
Fitzpatrick, A. L., Buchanan, C. K., Nahin, R. L., Dekosky, S. T., Atkinson, H. H., Carlson, M. 
C., et al. (2007). Associations of gait speed and other measures of physical function with 
cognition in a healthy cohort of elderly persons. J Gerontol A Biol Sci Med Sci, 62(11), 
1244-1251. 
 
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state". A practical 
method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12(3), 
189-198. 
 
Franklin, S. S. (2006a). Hypertension in older people: part 1. J Clin Hypertens (Greenwich), 
8(6), 444-449. 
 
Franklin, S. S. (2006b). Hypertension in older people: part 2. J Clin Hypertens (Greenwich), 
8(7), 521-525. 
 
Franklin, S. S., Jacobs, M. J., Wong, N. D., L'Italien, G. J., & Lapuerta, P. (2001). Predominance 
of isolated systolic hypertension among middle-aged and elderly US hypertensives: 
analysis based on National Health and Nutrition Examination Survey (NHANES) III. 
Hypertension, 37(3), 869-874. 
 
Fujiwara, Y., Chaves, P. H., Takahashi, R., Amano, H., Yoshida, H., Kumagai, S., et al. (2005). 
Arterial pulse wave velocity as a marker of poor cognitive function in an elderly 
community-dwelling population. J Gerontol A Biol Sci Med Sci, 60(5), 607-612. 
 
Fukuhara, M., Matsumura, K., Ansai, T., Takata, Y., Sonoki, K., Akifusa, S., et al. (2006). 
Prediction of cognitive function by arterial stiffness in the very elderly. Circ J, 70(6), 
756-761. 
 
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., et al. 
(2000). Lower extremity function and subsequent disability: consistency across studies, 
predictive models, and value of gait speed alone compared with the short physical 
performance battery. J Gerontol A Biol Sci Med Sci, 55(4), M221-231. 
 
Hajjar, I., & Kotchen, T. A. (2003). Trends in prevalence, awareness, treatment, and control of 
hypertension in the United States, 1988-2000. JAMA, 290(2), 199-206. 
 99 
 
Hajjar, I., Lackland, D. T., Cupples, L. A., & Lipsitz, L. A. (2007). Association between 
concurrent and remote blood pressure and disability in older adults. Hypertension, 50(6), 
1026-1032. 
 
Hanon, O., Haulon, S., Lenoir, H., Seux, M. L., Rigaud, A. S., Safar, M., et al. (2005). 
Relationship between arterial stiffness and cognitive function in elderly subjects with 
complaints of memory loss. Stroke, 36(10), 2193-2197. 
 
Hedeker, D., & Gibbons, R. D. (1997). Application of random-effects pattern-mixture models for 
missing data in longitudinal studies. Psychological Methods, 2, 64-78. 
 
Henskens, L. H., Kroon, A. A., van Oostenbrugge, R. J., Gronenschild, E. H., Fuss-Lejeune, M. 
M., Hofman, P. A., et al. (2008). Increased aortic pulse wave velocity is associated with 
silent cerebral small-vessel disease in hypertensive patients. Hypertension, 52(6), 1120-
1126. 
 
Hirata, K., Kawakami, M., & O'Rourke, M. F. (2006). Pulse wave analysis and pulse wave 
velocity: a review of blood pressure interpretation 100 years after Korotkov. Circ J, 
70(10), 1231-1239. 
 
Holtzer, R., Friedman, R., Lipton, R. B., Katz, M., Xue, X., & Verghese, J. (2007). The 
relationship between specific cognitive functions and falls in aging. Neuropsychology, 
21(5), 540-548. 
 
Holtzer, R., Verghese, J., Xue, X., & Lipton, R. B. (2006). Cognitive processes related to gait 
velocity: results from the Einstein Aging Study. Neuropsychology, 20(2), 215-223. 
 
Iadecola, C., Park, L., & Capone, C. (2008). Threats to the Mind. Aging, Amyloid, and 
Hypertension. Stroke. 
 
Iadecola, C., Park, L., & Capone, C. (2009). Threats to the mind: aging, amyloid, and 
hypertension. Stroke, 40(3 Suppl), S40-44. 
 
Intengan, H. D., & Schiffrin, E. L. (2000). Structure and mechanical properties of resistance 
arteries in hypertension: role of adhesion molecules and extracellular matrix 
determinants. Hypertension, 36(3), 312-318. 
 
Inzitari, M., Baldereschi, M., Di Carlo, A., Di Bari, M., Marchionni, N., Scafato, E., et al. 
(2007). Impaired attention predicts motor performance decline in older community-
dwellers with normal baseline mobility: results from the Italian Longitudinal Study on 
Aging (ILSA). J Gerontol A Biol Sci Med Sci, 62(8), 837-843. 
 
Inzitari, M., Newman, A. B., Yaffe, K., Boudreau, R., de Rekeneire, N., Shorr, R., et al. (2007). 
Gait Speed Predicts Decline in Attention and Psychomotor Speed in Older Adults: The 
Health Aging and Body Composition Study. Neuroepidemiology, 29(3-4), 156-162. 
 100 
 
Jokinen, H., Kalska, H., Ylikoski, R., Madureira, S., Verdelho, A., van der Flier, W. M., et al. 
(2009). Longitudinal Cognitive Decline in Subcortical Ischemic Vascular Disease - The 
LADIS Study. Cerebrovasc Dis, 27(4), 384-391. 
 
Kearney-Schwartz, A., Rossignol, P., Bracard, S., Felblinger, J., Fay, R., Boivin, J. M., et al. 
(2009). Vascular structure and function is correlated to cognitive performance and white 
matter hyperintensities in older hypertensive patients with subjective memory complaints. 
Stroke, 40(4), 1229-1236. 
 
Kritchevsky, S. B., Cesari, M., & Pahor, M. (2005). Inflammatory markers and cardiovascular 
health in older adults. Cardiovasc Res, 66(2), 265-275. 
 
Kuo, H. K., & Lipsitz, L. A. (2004). Cerebral white matter changes and geriatric syndromes: is 
there a link? J Gerontol A Biol Sci Med Sci, 59(8), 818-826. 
 
Lakatta, E. G. (1993). Cardiovascular regulatory mechanisms in advanced age. Physiol Rev, 
73(2), 413-467. 
 
Launer, L. J. (2004). Epidemiology of white matter lesions. Top Magn Reson Imaging, 15(6), 
365-367. 
 
Laurent, S., & Boutouyrie, P. (2007). Arterial stiffness: a new surrogate end point for 
cardiovascular disease? J Nephrol, 20 Suppl 12, S45-50. 
 
Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., et al. (2001). Aortic 
stiffness is an independent predictor of all-cause and cardiovascular mortality in 
hypertensive patients. Hypertension, 37(5), 1236-1241. 
 
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., et al. 
(2006). Expert consensus document on arterial stiffness: methodological issues and 
clinical applications. Eur Heart J, 27(21), 2588-2605. 
 
Lavery, L. L., Dodge, H. H., Snitz, B., & Ganguli, M. (2009). Cognitive decline and mortality in 
a community-based cohort: the Monongahela Valley Independent Elders Survey. J Am 
Geriatr Soc, 57(1), 94-100. 
 
Lee, Y., Kim, J. H., Lee, K. J., Han, G., & Kim, J. L. (2005). Association of cognitive status with 
functional limitation and disability in older adults. Aging Clin Exp Res, 17(1), 20-28. 
 
Liao, D., Arnett, D. K., Tyroler, H. A., Riley, W. A., Chambless, L. E., Szklo, M., et al. (1999). 
Arterial stiffness and the development of hypertension. The ARIC study. Hypertension, 
34(2), 201-206. 
 
Longstreth, W. T., Jr., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., et al. 
(1996). Clinical correlates of white matter findings on cranial magnetic resonance 
 101 
 
imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke, 27(8), 1274-
1282. 
 
Madero, M., Wassel, C. L., Peralta, C. A., Najjar, S. S., Sutton-Tyrrell, K., Fried, L., et al. 
(2009a). Cystatin C associates with arterial stiffness in older adults. J Am Soc Nephrol, 
20(5), 1086-1093. 
 
Madero, M., Wassel, C. L., Peralta, C. A., Najjar, S. S., Sutton-Tyrrell, K., Fried, L., et al. 
(2009b). Cystatin C Associates with Arterial Stiffness in Older Adults. J Am Soc 
Nephrol. 
 
Mahmud, A., & Feely, J. (2004). Arterial stiffness and the renin-angiotensin-aldosterone system. 
J Renin Angiotensin Aldosterone Syst, 5(3), 102-108. 
 
Manolio, T. A., Kronmal, R. A., Burke, G. L., Poirier, V., O'Leary, D. H., Gardin, J. M., et al. 
(1994). Magnetic resonance abnormalities and cardiovascular disease in older adults. The 
Cardiovascular Health Study. Stroke, 25(2), 318-327. 
 
Matsuoka, O., Otsuka, K., Murakami, S., Hotta, N., Yamanaka, G., Kubo, Y., et al. (2005). 
Arterial stiffness independently predicts cardiovascular events in an elderly community -- 
Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) 
study. Biomed Pharmacother, 59 Suppl 1, S40-44. 
 
Mazumdar, S., Tang, G., Houck, P. R., Dew, M. A., Begley, A. E., Scott, J., et al. (2007). 
Statistical analysis of longitudinal psychiatric data with dropouts. J Psychiatr Res, 
41(12), 1032-1041. 
 
McDermott, M. M., Liu, K., Greenland, P., Guralnik, J. M., Criqui, M. H., Chan, C., et al. 
(2004). Functional decline in peripheral arterial disease: associations with the ankle 
brachial index and leg symptoms. JAMA, 292(4), 453-461. 
 
McDonald, M., Hertz, R. P., Unger, A. N., & Lustik, M. B. (2009). Prevalence, awareness, and 
management of hypertension, dyslipidemia, and diabetes among United States adults 
aged 65 and older. J Gerontol A Biol Sci Med Sci, 64(2), 256-263. 
 
Melzer, I., & Oddsson, L. I. (2004). The effect of a cognitive task on voluntary step execution in 
healthy elderly and young individuals. J Am Geriatr Soc, 52(8), 1255-1262. 
 
Mitchell, G. F. (2008). Effects of central arterial aging on the structure and function of the 
peripheral vasculature: implications for end-organ damage. J Appl Physiol, 105(5), 1652-
1660. 
 
Mitchell, G. F., Vita, J. A., Larson, M. G., Parise, H., Keyes, M. J., Warner, E., et al. (2005). 
Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk 
 102 
 
factors, and aortic stiffness: the Framingham Heart Study. Circulation, 112(24), 3722-
3728. 
 
Mottram, P. M., Haluska, B. A., Leano, R., Carlier, S., Case, C., & Marwick, T. H. (2005). 
Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart, 
91(12), 1551-1556. 
 
Mourad, J. J., Pannier, B., Blacher, J., Rudnichi, A., Benetos, A., London, G. M., et al. (2001). 
Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. 
Kidney Int, 59(5), 1834-1841. 
 
Muller, M., Grobbee, D. E., Aleman, A., Bots, M., & van der Schouw, Y. T. (2007). 
Cardiovascular disease and cognitive performance in middle-aged and elderly men. 
Atherosclerosis, 190(1), 143-149. 
 
Najjar, S. S., Scuteri, A., & Lakatta, E. G. (2005). Arterial aging: is it an immutable 
cardiovascular risk factor? Hypertension, 46(3), 454-462. 
 
Najjar, S. S., Scuteri, A., Shetty, V., Wright, J. G., Muller, D. C., Fleg, J. L., et al. (2008). Pulse 
wave velocity is an independent predictor of the longitudinal increase in systolic blood 
pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J 
Am Coll Cardiol, 51(14), 1377-1383. 
 
Newman, A. B., Arnold, A. M., Sachs, M. C., Ives, D. G., Cushman, M., Strotmeyer, E. S., et al. 
(2009). Long-term function in an older cohort--the cardiovascular health study all stars 
study. J Am Geriatr Soc, 57(3), 432-440. 
 
Newman, A. B., Shemanski, L., Manolio, T. A., Cushman, M., Mittelmark, M., Polak, J. F., et al. 
(1999). Ankle-arm index as a predictor of cardiovascular disease and mortality in the 
Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler 
Thromb Vasc Biol, 19(3), 538-545. 
 
Newman, A. B., Simonsick, E. M., Naydeck, B. L., Boudreau, R. M., Kritchevsky, S. B., Nevitt, 
M. C., et al. (2006). Association of long-distance corridor walk performance with 
mortality, cardiovascular disease, mobility limitation, and disability. JAMA, 295(17), 
2018-2026. 
 
O'Rourke, M. F. (2007). Arterial aging: pathophysiological principles. Vasc Med, 12(4), 329-
341. 
 
O'Rourke, M. F., & Safar, M. E. (2005). Relationship between aortic stiffening and 
microvascular disease in brain and kidney: cause and logic of therapy. Hypertension, 
46(1), 200-204. 
 103 
 
O'Rourke, M. F., Staessen, J. A., Vlachopoulos, C., Duprez, D., & Plante, G. E. (2002). Clinical 
applications of arterial stiffness; definitions and reference values. Am J Hypertens, 15(5), 
426-444. 
 
O'Sullivan, M., Morris, R. G., & Markus, H. S. (2005). Brief cognitive assessment for patients 
with cerebral small vessel disease. J Neurol Neurosurg Psychiatry, 76(8), 1140-1145. 
 
Ohmine, T., Miwa, Y., Yao, H., Yuzuriha, T., Takashima, Y., Uchino, A., et al. (2008). 
Association between arterial stiffness and cerebral white matter lesions in community-
dwelling elderly subjects. Hypertens Res, 31(1), 75-81. 
 
Oliver, J. J., & Webb, D. J. (2003). Noninvasive assessment of arterial stiffness and risk of 
atherosclerotic events. Arterioscler Thromb Vasc Biol, 23(4), 554-566. 
 
Ovbiagele, B., & Saver, J. L. (2006). Cerebral white matter hyperintensities on MRI: Current 
concepts and therapeutic implications. Cerebrovasc Dis, 22(2-3), 83-90. 
 
Pantoni, L. (2002). Pathophysiology of age-related cerebral white matter changes. Cerebrovasc 
Dis, 13 Suppl 2, 7-10. 
 
Park, J. B., & Schiffrin, E. L. (2001). Small artery remodeling is the most prevalent (earliest?) 
form of target organ damage in mild essential hypertension. J Hypertens, 19(5), 921-930. 
 
Penninx, B. W., Kritchevsky, S. B., Newman, A. B., Nicklas, B. J., Simonsick, E. M., Rubin, S., 
et al. (2004). Inflammatory markers and incident mobility limitation in the elderly. J Am 
Geriatr Soc, 52(7), 1105-1113. 
 
Perera, S., Studenski, S., Chandler, J. M., & Guralnik, J. M. (2005). Magnitude and patterns of 
decline in health and function in 1 year affect subsequent 5-year survival. J Gerontol A 
Biol Sci Med Sci, 60(7), 894-900. 
 
Poels, M. M., van Oijen, M., Mattace-Raso, F. U., Hofman, A., Koudstaal, P. J., Witteman, J. C., 
et al. (2007). Arterial stiffness, cognitive decline, and risk of dementia: the Rotterdam 
study. Stroke, 38(3), 888-892. 
 
Prins, N. D., van Dijk, E. J., den Heijer, T., Vermeer, S. E., Jolles, J., Koudstaal, P. J., et al. 
(2005). Cerebral small-vessel disease and decline in information processing speed, 
executive function and memory. Brain, 128(Pt 9), 2034-2041. 
 
Pugh, K. G., & Lipsitz, L. A. (2002). The microvascular frontal-subcortical syndrome of aging. 
Neurobiol Aging, 23(3), 421-431. 
 
Reitan, R. M. (1958). Validity of the trail making test as an indicator of organic brain damage. 
Perceptual Motor Skills, 8, 271-276. 
 104 
 
Roriz-Cruz, M., Rosset, I., Wada, T., Sakagami, T., Ishine, M., De Sa Roriz-Filho, J., et al. 
(2007). Cognitive impairment and frontal-subcortical geriatric syndrome are associated 
with metabolic syndrome in a stroke-free population. Neurobiol Aging, 28(11), 1723-
1736. 
 
Rosano, C., Aizenstein, H. J., Studenski, S., & Newman, A. B. (2007). A regions-of-interest 
volumetric analysis of mobility limitations in community-dwelling older adults. J 
Gerontol A Biol Sci Med Sci, 62(9), 1048-1055. 
 
Rosano, C., Kuller, L. H., Chung, H., Arnold, A. M., Longstreth, W. T., Jr., & Newman, A. B. 
(2005). Subclinical brain magnetic resonance imaging abnormalities predict physical 
functional decline in high-functioning older adults. J Am Geriatr Soc, 53(4), 649-654. 
 
Rosano, C., Newman, A. B., Katz, R., Hirsch, C. H., & Kuller, L. H. (2008). Association 
between lower digit symbol substitution test score and slower gait and greater risk of 
mortality and of developing incident disability in well-functioning older adults. J Am 
Geriatr Soc, 56(9), 1618-1625. 
 
Rosano, C., Simonsick, E. M., Harris, T. B., Kritchevsky, S. B., Brach, J., Visser, M., et al. 
(2005). Association between physical and cognitive function in healthy elderly: the 
health, aging and body composition study. Neuroepidemiology, 24(1-2), 8-14. 
 
Rosenbaum, P. R., & Rubin, D. B. (1984). Reducing bias in observational studies using 
subclassification on the propensity score. Journal of American Statistical Association, 79, 
516-524. 
 
Royall, D. R., Mahurin, R. K., & Gray, K. F. (1992). Bedside assessment of executive cognitive 
impairment: the executive interview. J Am Geriatr Soc, 40(12), 1221-1226. 
 
Royall, D. R., Palmer, R., Chiodo, L. K., & Polk, M. J. (2004). Declining executive control in 
normal aging predicts change in functional status: the Freedom House Study. J Am 
Geriatr Soc, 52(3), 346-352. 
 
Sachdev, P. S., Wen, W., Christensen, H., & Jorm, A. F. (2005). White matter hyperintensities 
are related to physical disability and poor motor function. J Neurol Neurosurg 
Psychiatry, 76(3), 362-367. 
 
Safar, M. E., & Lacolley, P. (2007). Disturbance of macro- and microcirculation: relations with 
pulse pressure and cardiac organ damage. Am J Physiol Heart Circ Physiol, 293(1), H1-
7. 
 
Safar, M. E., London, G. M., & Plante, G. E. (2004). Arterial stiffness and kidney function. 
Hypertension, 43(2), 163-168. 
 
 105 
 
Salthouse, T. A. (1996). General and specific speed mediation of adult age differences in 
memory. J Gerontol B Psychol Sci Soc Sci, 51(1), P30-42. 
 
Sasamura, H., Kitamura, Y., Nakamura, M., Ryuzaki, M., & Saruta, T. (2006). Effects of the 
angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular 
matrix metabolism in patients with essential hypertension. Clin Exp Hypertens, 28(5), 
511-520. 
 
Schafer, J. L. (1997). Analysis of incomplete multivariate data. London: Chapman & Hall. 
 
Schiffrin, E. L. (2004). Vascular stiffening and arterial compliance. Implications for systolic 
blood pressure. Am J Hypertens, 17(12 Pt 2), 39S-48S. 
 
Schupf, N., Tang, M. X., Albert, S. M., Costa, R., Andrews, H., Lee, J. H., et al. (2005). Decline 
in cognitive and functional skills increases mortality risk in nondemented elderly. 
Neurology, 65(8), 1218-1226. 
 
Scuteri, A., Brancati, A. M., Gianni, W., Assisi, A., & Volpe, M. (2005). Arterial stiffness is an 
independent risk factor for cognitive impairment in the elderly: a pilot study. J 
Hypertens, 23(6), 1211-1216. 
 
Scuteri, A., Tesauro, M., Appolloni, S., Preziosi, F., Brancati, A. M., & Volpe, M. (2007). 
Arterial stiffness as an independent predictor of longitudinal changes in cognitive 
function in the older individual. J Hypertens, 25(5), 1035-1040. 
 
Selvin, E., & Erlinger, T. P. (2004). Prevalence of and risk factors for peripheral arterial disease 
in the United States: results from the National Health and Nutrition Examination Survey, 
1999-2000. Circulation, 110(6), 738-743. 
 
Semba, R. D., Ferrucci, L., Sun, K., Walston, J., Varadhan, R., Guralnik, J. M., et al. (2007). 
Oxidative stress and severe walking disability among older women. Am J Med, 120(12), 
1084-1089. 
 
Silbert, L. C., Nelson, C., Howieson, D. B., Moore, M. M., & Kaye, J. A. (2008). Impact of 
white matter hyperintensity volume progression on rate of cognitive and motor decline. 
Neurology, 71(2), 108-113. 
 
Simm, A., Nass, N., Bartling, B., Hofmann, B., Silber, R. E., & Navarrete Santos, A. (2008). 
Potential biomarkers of ageing. Biol Chem, 389(3), 257-265. 
 
Simonsick, E. M., Montgomery, P. S., Newman, A. B., Bauer, D. C., & Harris, T. (2001). 
Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk. 
J Am Geriatr Soc, 49(11), 1544-1548. 
 
 106 
 
Skoog, I., & Gustafson, D. (2006). Update on hypertension and Alzheimer's disease. Neurol Res, 
28(6), 605-611. 
 
Soumare, A., Tavernier, B., Alperovitch, A., Tzourio, C., & Elbaz, A. (2009). A cross-sectional 
and longitudinal study of the relationship between walking speed and cognitive function 
in community-dwelling elderly people. J Gerontol A Biol Sci Med Sci, 64(10), 1058-
1065. 
 
Spiers, N. A., Matthews, R. J., Jagger, C., Matthews, F. E., Boult, C., Robinson, T. G., et al. 
(2005). Diseases and impairments as risk factors for onset of disability in the older 
population in England and Wales: findings from the Medical Research Council Cognitive 
Function and Ageing Study. J Gerontol A Biol Sci Med Sci, 60(2), 248-254. 
 
Starr, J. M., Leaper, S. A., Murray, A. D., Lemmon, H. A., Staff, R. T., Deary, I. J., et al. (2003). 
Brain white matter lesions detected by magnetic resonance [correction of resosnance] 
imaging are associated with balance and gait speed. J Neurol Neurosurg Psychiatry, 
74(1), 94-98. 
 
Stern, Y. (2009). Cognitive reserve. Neuropsychologia, 47(10), 2015-2028. 
 
Sutton-Tyrrell, K., Najjar, S. S., Boudreau, R. M., Venkitachalam, L., Kupelian, V., Simonsick, 
E. M., et al. (2005). Elevated aortic pulse wave velocity, a marker of arterial stiffness, 
predicts cardiovascular events in well-functioning older adults. Circulation, 111(25), 
3384-3390. 
 
Tekin, S., & Cummings, J. L. (2002). Frontal-subcortical neuronal circuits and clinical 
neuropsychiatry: an update. J Psychosom Res, 53(2), 647-654. 
 
Teng, E. L., & Chui, H. C. (1987). The Modified Mini-Mental State (3MS) examination. J Clin 
Psychiatry, 48(8), 314-318. 
 
Thompson, C. S., & Hakim, A. M. (2009). Living beyond our physiological means: small vessel 
disease of the brain is an expression of a systemic failure in arteriolar function: a unifying 
hypothesis. Stroke, 40(5), e322-330. 
 
Tracy, R. P. (2003). Emerging relationships of inflammation, cardiovascular disease and chronic 
diseases of aging. Int J Obes Relat Metab Disord, 27 Suppl 3, S29-34. 
 
Triantafyllidi, H., Arvaniti, C., Lekakis, J., Ikonomidis, I., Siafakas, N., Tzortzis, S., et al. 
(2009). Cognitive impairment is related to increased arterial stiffness and microvascular 
damage in patients with never-treated essential hypertension. Am J Hypertens, 22(5), 
525-530. 
 
 107 
 
van Gelder, B. M., Tijhuis, M. A., Kalmijn, S., Giampaoli, S., & Kromhout, D. (2007). Decline 
in cognitive functioning is associated with a higher mortality risk. Neuroepidemiology, 
28(2), 93-100. 
 
van Iersel, M. B., Kessels, R. P., Bloem, B. R., Verbeek, A. L., & Olde Rikkert, M. G. (2008). 
Executive functions are associated with gait and balance in community-living elderly 
people. J Gerontol A Biol Sci Med Sci, 63(12), 1344-1349. 
 
van Popele, N. M., Grobbee, D. E., Bots, M. L., Asmar, R., Topouchian, J., Reneman, R. S., et 
al. (2001). Association between arterial stiffness and atherosclerosis: the Rotterdam 
Study. Stroke, 32(2), 454-460. 
 
Vermeer, S. E., Longstreth, W. T., Jr., & Koudstaal, P. J. (2007). Silent brain infarcts: a 
systematic review. Lancet Neurol, 6(7), 611-619. 
 
Waldstein, S. R., Rice, S. C., Thayer, J. F., Najjar, S. S., Scuteri, A., & Zonderman, A. B. (2008). 
Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore 
Longitudinal Study of Aging. Hypertension, 51(1), 99-104. 
 
Wardlaw, J. M., Sandercock, P. A., Dennis, M. S., & Starr, J. (2003). Is breakdown of the blood-
brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke, 34(3), 
806-812. 
 
Wechsler Adult Intelligence Scale F Revised. (1981). San Antonio, TX: Psychological 
Corporation. 
 
Yao, S. T., Hobbs, J. T., & Irvine, W. T. (1969). Ankle systolic pressure measurements in arterial 
disease affecting the lower extremities. Br J Surg, 56(9), 676-679. 
 
Zeger, S. L., Liang, K. Y., & Albert, P. S. (1988). Models for longitudinal data: a generalized 
estimating equation approach. Biometrics, 44(4), 1049-1060. 
 
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005). Mechanisms, pathophysiology, and 
therapy of arterial stiffness. Arterioscler Thromb Vasc Biol, 25(5), 932-943. 
 
